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 Modeling and computational tools are proven to be extremely successful in streamlining the design 
and engineering of different systems in many areas of science and engineering. However, due to its complex 
nature, modeling in biology is in an early stage and many more years of development is required to achieve 
the level of confidence that exists today on software packages like SOLIDWORKS suite and COMSOL on 
models in biology. For instance, the timescale of reliable modeling of a small protein is in the nano to 
microsecond range even with the most sophisticated supercomputers, let alone modeling of entire 
microorganisms in timescales of a few hours. One of the ways to overcome this limitation is to treat any 
specific system like a black box and increase the number of inputs or evaluations and learn the system by 
observing the output corresponding to each input. This solution requires large amounts of data to achieve a 
reliable predictive model of the system, which may be acquired where data acquisition is inexpensive and 
high-throughput screening methods are available. However, when the evaluations are expensive, other tools 
like automation or machine learning algorithms could be used to both reduce the cost of the evaluations and 
get more information with fewer evaluations. Here, computational tools and methods were developed to 
enable the generation of large scale inputs to the bio systems and provide useful insights from the output. 
For cases with difficult evaluations, a machine learning algorithm was used for choosing the most 
informative inputs to generate more insight from fewer experiments and evaluations. 
First, xylose utilization was chosen to show the effectiveness of large scale screening to improve 
this phenotype. Xylose is a major component of lignocellulosic biomass, one of the most abundant 
feedstocks for biofuel production. Therefore, efficient and rapid conversion of xylose to ethanol is crucial 
in the viability of lignocellulosic biofuel plants. Here, RNAi Assisted Genome Evolution (RAGE) was used 
to improve the xylose utilization rate in SR8, one of the most efficient publicly available xylose utilizing 
Saccharomyces cerevisiae strains. To identify gene targets for further improvement, we created a genome-
scale library consisting of both genetic over-expression and down-regulation mutations in SR8. Followed 
by screening in media containing xylose as the sole carbon source, yeast mutants with 29% faster xylose 
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utilization and 45% higher ethanol productivity were obtained relative to the parent strain. Two known and 
two new effector genes were identified in these mutant strains. Notably, down-regulation of CDC11, an 
essential gene, resulted in faster xylose utilization, and this gene target cannot be identified in genetic 
knock-out screens. 
This type of large-scale screening is only possible where a high-throughput screening method is 
available which was the case for xylose utilization. Unfortunately, most phenotypes lack this type of high-
throughput assay and each evaluation is relatively expensive and time-consuming, making the evaluation 
of millions of assays practically impossible. This problem can be solved by taking advantage of machine 
learning algorithms, automation as well as a smart library design. A successful example of reducing the 
number of evaluations is presented here. The general approach of this methods is engineering the regulatory 
elements, typically promoters, to modify expression levels of the genes involved in the biosynthetic 
pathway and then evaluating some points in the expression production landscape and using a computational 
model to estimate the rest of the landscape. The entire process was performed using the Illinois Biological 
Foundry for Advanced Biomanufacturing (iBioFAB) where the initial system was set up and the algorithm 
picks the points to be evaluated and returns them to the iBioFAB. iBioFAB then performed the experiments 
dictated by the algorithm and returned the results back to the algorithm to get the next experiments to 
perform. This machine-algorithm hybrid Robo-Scientist generated hypotheses, tested them and used the 
result as the basis for generating new hypotheses, keeping an eye on its goal of optimizing the biosystem 
of interest. Bayesian optimization with Gaussian Process as the prior was used for learning from the outputs 
of the expression-production landscape. Using three rounds of machine learning driven pathway 
optimization with evaluating less than 1% of the total possibilities, this Robo-Scientist outperformed 
random screening by 1.77 folds. 
Golden Gate assembly was used as the method of choice for construction of the plasmid library in 
this project. However, efficient and high-fidelity assembly was key to successful implementation of this 
workflow on iBioFAB. It has been shown that the DNA sequences used as linkers in Golden Gate assembly 
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are an important factor in its efficiency. Here, a DNA assembly and sequencing scheme was designed and 
tested to assess the efficiency of different linkers for this application. 200 linker sets with sizes from 10 to 
50 with high efficiency and fidelity were found and reported to be used to achieve high efficiency in Golden 
Gate assembly. These optimized linkers were also used to achieve scar-less Golden Gate assembly and BsaI 
removal. In this method, optimized overhangs are found in the areas next to the ends of the DNA parts and 
a BsaI recognition site is added to the optimized linkers using PCR amplification. 
For efficient implementation of these and similar projects, other computational tools are required 
to both design large scale libraries and smaller smart libraries that are adaptively designed based on the data 
acquired from the experiments. Two guide RNA design tools were developed and used to design more than 
one million guide RNAs and more than one hundred thousand of the designed guide RNAs were 
synthesized and used in multiple projects. These molecules performed a variety of functions from large-
scale gene activation, interference and deletion to genome editing with base pair resolution. The iBioCAD 
design tool was also developed to enable large-scale library design and construction using a variety of 
methods, including the novel scar-less Golden Gate assembly method described above. 
Finally, to solve one of the main bottlenecks in automation of the DNA assembly, a high-throughput 
DNA separation device was designed and tested. This high-throughput and compact vertical gel 
electrophoresis system would enable separation of 48 samples at a time and is compatible with most 
automated liquid handling systems due to the use of standard formats. The vertical gel electrophoresis 
system was set up and tested but the robust device with automatic size fractionation and detection needs 
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Chapter 1: Introduction 
 
1.1. Engineering microbial cell factories  
 
 Over the last few decades, intensive exploitation of natural sources and increasing environmental 
concerns have motivated a growing interest in developing sustainable processes to produce fuels, 
commodity chemicals, and natural products (1, 2). Microorganisms have emerged as suitable platforms to 
produce a range of compounds that are sustainable, environmentally friendly, and cost-effective (3–5). In 
nature, microorganisms have exhibited wide metabolic versatility, allowing them to produce a variety of 
chemicals. This ability has been exploited by the scientific community to develop microbial cell factories 
to synthesize desired chemicals. In some cases, the chemical of interest is an endogenous metabolite and 
can be produced in the original organism. However, native pathways are usually tightly regulated and do 
not fulfill industrial productivity expectations. Therefore, overproduction of the desired compound can be 
achieved by metabolic engineering of the native host in a number of ways; for example, channeling cellular 
flux toward the desired pathway or modulating cellular regulatory networks. In other cases, natural 
pathways or synthetic pathways combining enzymes from different organisms or even new enzymes can 
be inserted in a more suitable heterologous host to produce the chemical of interest. Nevertheless, multi-
enzymatic pathways from different species may not function optimally in the desired host. Causes for low 
or no production of the desired molecule are often multifactorial including failure of the pathway, cell 
perturbations such as growth impairment, accumulation of metabolites, generation of toxic intermediates, 
and oxidative stress (6). Production of the target chemical can be achieved not only by optimizing the 
biochemical pathway but also by engineering the host microorganism. In this case, the overall metabolic 
performance of a cell may be improved by modulating gene expression on a genome scale using traditional 
gene deletion methods or more recent techniques involving small regulatory ribonucleic acids (RNAs) (7, 
8). 
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 Rational optimization for increasing the productivity of these strains have proven difficult due to 
the complexity of biological systems as well as the myriad of components of these systems and the many 
unknown interactions among them. These difficulties have called for treating biological system like black-
box functions and trying many different inputs and changes in the system and studying the effect of each 
input on the output of the system. While the function evaluation is relatively inexpensive and easy, the 
number of these inputs can increase to tens of millions which is most commonly used in genome scale 
engineering approaches. However, in many cases, due to the high cost of evaluations, other methods should 
be implemented for smart selection of inputs to learn the most about the system without many evaluations.    
1.2. Large scale libraries and screening 
1.2.1. Applications of large scale libraries 
 Large scale genome engineering has been shown to be an extremely effective way of improving 
different phenotypes when there is not much known about the biological system in question. These 
approaches are most effective when there is a high-throughput screening method available and the best 
changes to the system can be found with relatively low cost and effort (9).  The phenotypes in these systems 
are typically either growth-associated or the effect of the desired phenotype can be linked to a fluorescent 
signal with a reliable biosensor (10). Since there are  relatively few reliable biosensors reported in the 
literature, most large-scale libraries focus on growth-associated targets. This method has been used 
extensively for improving xylose utilization (11) or cellobiose consumption rate (12).  There have been 
many studies using this approach for improving the tolerance of microbial strains to common inhibitors 
found in industrial fermentation broth. In most of these studies, a DNA library is constructed that induces 
many changes in the genome of the host, then a selection pressure like the addition of furfural to the media 
or providing xylose to the cells as the sole carbon source is used to enrich and identify the beneficial 
changes. Approaches like Multiplex Automated Genome Engineering (MAGE) (13) and Trackable 
Multiplex Recombineering (TRMR) (14), were also used for making these changes but RNAi Machinery 
and CRISPR technology are the focus of this thesis. Large scale libraries targeting expression levels of 
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thousands of genes in the yeast genome have been constructed and a high-throughput screening was used 
to find the most beneficial mutations. 
1.2.2. RNAi assisted genome engineering 
 RNA interference is a biological process where an RNA molecule inhibits the expression of a gene 
by binding to the transcribed mRNA from that gene and neutralizing it (15). This machinery has been used 
for reducing the expression level of target genes in the genome and evaluating its effect on cell behavior. 
Although RNA interference (RNAi) is a common gene silencing mechanism in eukaryotes (16), the model 
yeast, Saccharomyces cerevisiae, lacks a native RNAi pathway (15).  The recent reconstitution of RNAi 
machinery in S. cerevisiae enables the use of this powerful tool for yeast genome engineering (15).  
Enzymatic genomic DNA fragments were cloned into a pair of convergent constitutive promoters to 
construct double-stranded RNA libraries for genome-wide silencing (17).  Screening using the resultant 
library identified suppressors of a telomere-defect mutation and genetic determinants for improved 
tolerance towards lignocellulosic hydrolysate inhibitors (18).  Moreover, RNAi-assisted genome evolution 
(RAGE) enables continuous improvement of a target phenotype by down-regulating all genes in the genome 
and finding the most beneficial down-regulation and utilizing that mutant for further rounds of down-
regulation (17).  During one round of RAGE, several single knockdown modifications were first identified 
by RNAi screening and then integrated into the yeast genome to create new parent strains for the next round 
of engineering.  Multiplex knockdown mutations were therefore accumulated to improve complex traits in 
S. cerevisiae (19). 
1.2.3. CRISPR assisted genome engineering 
 The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated 
protein (Cas) provides an RNA-mediated interference system that cleaves DNA (20).  Specifically, the type 
II Streptococcus pyogenes CRISPR-Cas system offers a simple configuration that contains only a single 
endonuclease (Cas9).  Trans-activating RNA (tracr-RNA) facilitates the processing of CRISPR RNA 
(crRNA) by Cas9 and the Cas9-crRNA complex introduces a double stranded break (DSB) at the targeted 
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genome locus.  The specificity of target recognition is determined by the guide sequence in crRNA followed 
by a short sequence called protospacer adjacent motif (PAM) (21).  The DSBs introduced by CRISPR-Cas 
can substantially improve the genome engineering efficiency by stimulating the efficiency of Non-
homologous End Joining (NHEJ) or Homology Recombination (HR) (22).  This versatile framework has 
already been applied in a wide range of organisms including bacteria (23),  yeast (24), plant (25), animal 
(26, 27), and human cells (22, 28). 
 In microbial genome engineering, multiplex genome editing is desirable to accelerate strain 
prototyping and combinatorial optimization.  In S. cerevisiae, three genes were simultaneously disrupted 
with high efficiency using the Homology-Integrated CRISPR-Cas (HI-CRISPR) system, where 
homologous knockout donors were inserted before the 5’ end of the guide sequences in crRNAs.  This 
configuration permitted integration of all the necessary CRISPR elements in a single ultrahigh copy 
plasmid, and therefore achieved high gene disruption efficiency (29).  
 In addition to genome editing, the CRISPR-Cas system has been expanded for gene regulation 
without altering the target DNA sequences.  To achieve this goal, a deactivated Cas9 (dCas9) protein 
abolished with endonuclease activity was created (30).  It was found that efficient gene silencing (1,000-
fold reduction) was achieved when the non-template DNA strand was targeted by dCas9/crRNA complex, 
which blocked transcriptional initiation or elongation (30).  The CRISPR interference (CRIPSRi) system 
has been successfully demonstrated in E. coli, yeast and mammalian cells (31). In addition, when fused 
with transcriptional factors, dCas9 could accomplish more modes of gene regulation.   For example, gene 
activation was achieved in E. coli and yeast, when dCas9 was fused to the omega subunit of bacterial RNA 
polymerase or yeast transcriptional activator domains, respectively. Likewise, gene silencing efficiency 
was improved by fusing dCas9 to transcription repressors or chromatin silencers (31). 
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1.3. Smart libraries and screening for pathway optimization 
1.3.1. Pathway optimization  
 A designed pathway often does not function optimally in the desired host. Therefore, it is crucial 
to optimize several factors to obtain a functional and efficient pathway. The introduction of a set of 
heterologous genes usually entails a metabolic burden for the host. As a result, the chemical of interest may 
not be produced in yields that fulfill the expectations of industrial implementation. To alleviate metabolic 
stress and hence increase the yield of the target chemical, the expression of a heterologous pathway can be 
improved by tuning a few parameters that affect either the transcription and/or the translation processes. 
One of the major tools in pathway optimization is tuning the expression level of the genes involved in the 
biosynthesis of the compound of interest, specifically using promoter engineering. 
 The promoter is a control element with great influence on gene expression as strong promoters 
usually result in increased mRNA levels. Therefore, increasing the promoter strength is a successful 
approach to enhance protein expression. Nevertheless, in multi-gene pathways, this approach can lead to 
transcriptional/ translational stress, accumulation of metabolites, and toxicity. To prevent these problems, 
balancing the promoter strength among pathway genes is essential. Recently, there have been  efforts to 
characterize and develop libraries of natural/hybrid/synthetic promoters with a dynamic range in terms of 
promoter strength that allow the precise regulation of each gene in the pathway (12, 32–35).  
1.3.2. Smart library design 
 Large scale library creation and screening is a powerful method for understanding and optimization 
of systems of interest when evaluation of the system is cost effective and quick and millions of variations 
can be evaluated in a reasonable time-scale. Unfortunately, most phenotypes lack this type of high-
throughput assay and each evaluation is relatively expensive and time-consuming, making the evaluation 
of millions of assays practically impossible. This problem can be solved by taking advantage of machine 
learning algorithms as well as smart library design. 
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 There have been a few successful examples of reducing the number of evaluations with creative 
methods. The general approach of these methods is engineering the regulatory elements, typically 
promoters, to modify expression levels of the genes involved in the biosynthetic pathway and then evaluate 
some points in the expression production landscape and use a computational model to estimate the rest of 
the landscape.  Lee and co-workers (36) trained Exterior Derivative Estimation, a regression model with 
certain constraints (37) on 96 points evaluated from the expression-production landscape and were able to 
predict 96 other random points with an impressive R-value of 0.81. In another example, a biophysical model 
was used for designing different Ribosome Binding Sites (RBS) with different translation initiation rates 
and a translation based expression production landscape was evaluated (38). Based on the initial results of 
the landscape, they would then zoom in on the promising region and evaluate more points, significantly 
reducing the number of evaluations. 
1.4. Project overview 
 This dissertation focuses on identifying the beneficial perturbations of microbial genomes by 
making many modifications and using high-throughput screening or machine learning to determine the best 
modifications as well as developing tools to facilitate the design of large scale and smart libraries for 
perturbations (Figure 1.1). The insufficient knowledge of biological systems and the myriad of unknown 
interactions significantly limits our ability for rational design. One successful solution, which is the basis 
of directed evolution, is large scale library creation and screening. This method of screening was used for 
improving xylose utilization in Saccharomyces cerevisiae. For cases where large scale screening is not 
feasible, a machine learning algorithm was also used in combination with a fully-automated robotic 
platform and was able to find the optimal combination for lycopene production by trying less than 1% of 
the total number of possibilities.  
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Figure 1.1. Three main areas discussed in this dissertation are addressing the black-box evaluation problem 
where evaluations are inexpensive (Chapter 2), using machine learning for lowering the number of 
evaluations where they are expensive (Chapter 3) and developing novel computational programs (Chapter 
5) and biological processes (Chapter 4) and devices (Chapter 6) for reducing the cost and automating 
evaluations as well as enabling technologies to perform more evaluations.  
Chapter 2 focuses on using cDNA libraries combined with RAGE to down-regulate and over-
express all the genes in the S. cerevisiae genome and performing large scale screening to find beneficial 
modifications. Four genes, VPS13, CDC11, COX5A, and MDH1 were identified whose modification greatly 
improved xylose utilization. The xylose utilization rate and ethanol productivity of the best mutant were 
improved by 29% and 45%, respectively over the original strain. 
In Chapter 3, a method was introduced that can reduce the number of evaluations for cases where 
experiments are expensive, and a high-throughput screening method is not available. Bayesian optimization 
with a Gaussian Process as the prior was used to balance lycopene production pathway in Escherichia coli 
as a proof of concept.  The process predicted by machine learning that the best mutant produced 1.77 times 
more lycopene than the best mutant found in a random screening of the same number of points. The 
experiments described in this chapter were performed automatically using the Illinois Biological Foundry 
for Advanced Biomanufacturing (iBioFAB) platform. The experiments were designed by a Bayesian 
optimization algorithm and were given to iBioFAB. The experiments and analysis were then performed by 
iBioFAB and the results were given to the machine learning algorithm. The fully-automated design, build, 
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test and learn cycle with an algorithm to minimize the total number of experiments demonstrated an efficient 
fully-automated platform with adaptive sampling and its use in pathway optimization. 
In Chapter 4, the Golden Gate assembly method, one of the most versatile and robust assembly 
methods used in pathway engineering as described in Chapter 3, was optimized and two major problems 
with this assembly method were solved. High-throughput DNA synthesis and Next Generation Sequencing 
were used to find the compatibility and efficiency of Golden Gate overhangs. These optimized overhangs 
can greatly increase the efficiency and fidelity of Golden Gate assembly, making the assembly less error 
prone and more automation friendly. These optimized overhangs can also be used for single-pot scar-less 
Golden Gate assembly and BsaI removal.  We demonstrated this with a three-piece Golden Gate reaction 
as a proof of concept. 
Chapter 5 focuses on the design software tools used for both large scale guide RNA as well as small 
scale plasmid design. Using the guide RNA design tool, more than 1,000,000 guide RNA molecules were 
designed and sorted based on a variety of criteria to target all open reading frames in the S. cerevisiae 
genome performing activation, interference, and deletion of the target genes(39, 40). The gRNAs were also 
used to introduce point mutations in the genome and create libraries mutating specific regions of genes to 
other amino acids and find the effect on the gene function. This chapter also introduces iBioCAD, a web 
application for large scale plasmid design that can be used for designing combinatorial pathways for small 
and large-scale engineering. The optimized overhangs for Golden Gate assembly obtained in chapter 4 were 
also integrated into this program and the program directly designs primers for one-step single-pot scar-less 
Golden Gate assembly and BsaI removal. The combination of iBioCAD and gRNA design software can 
help in the design of a wide range of libraries from a single plasmid to hundreds of thousands of gRNAs 
for targeting all genes in a genome. 
Finally, Chapter 6 describes a vertical gel electrophoresis device for high-throughput DNA size 
fractionation and purification. DNA purification is a key step in automated pathway engineering and a 
critical step after PCR reactions, significantly improving the DNA assembly efficiency. This device will 
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help accelerate and automate PCR purification while reducing the footprint and cost, enabling automation, 
and fast and reliable DNA purification for construction of DNA libraries. 
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Global warming and the instability of energy resources with fluctuating prices have resulted in an 
increasing interest in alternative energy resources (1), with biofuels as one promising option. Each year, 
billions of gallons of bioethanol are produced in the United States alone, but they are primarily produced 
from food feedstocks such as corn starch and sugarcane, urging the exploration of alternative feedstock 
sources such as agricultural residues and non-food crops (Ha et al., 2011; Jeffries and Jin, 2004; Lian et al., 
2014; Wei et al., 2015). Lignocellulosic agricultural residues account for more than half of the agricultural 
phytomass in the world (6), and are considered a cost effective feedstock for biofuel production (7). Other 
than incentives from the Environmental Protection Agency and Renewable Fuel Standard to move beyond 
corn biofuel, there are tremendous economic incentives to switch to low-cost lignocellulose. 
Saccharomyces cerevisiae is one of the most widely used cell factories for the conversion of sugar 
to biofuels, thanks to its tolerance to harsh industrial conditions and resistance to phage contamination (8). 
However, S. cerevisiae cannot consume all lignocellulose-derived sugars, such as xylose, which may 
comprise up to 40% of the total sugars. Substantial improvement in xylose conversion may contribute to 
economically feasible production of lignocellulosic ethanol, and there have been many studies on 
engineering S. cerevisiae strains to improve xylose utilization (9–11). Successful strategies include protein 
engineering of xylose transporters (12, 13) and assimilation enzymes (5), as well as pathway engineering 
targeting flux optimization (14, 15) and co-factor imbalance (16, 17), which are all among the most 
powerful pathway optimization methods (18). Despite these extensive efforts, however, low xylose 
utilization rate and biofuel productivity are still major hurdles to commercializing lignocellulosic biofuel 
production.  
Resultant from both rational and evolutionary engineering, SR8 is one of the fastest growing and 
most efficient xylose utilizing strains ever reported in literature (19).  Serial sub-culturing in xylose media 
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revealed a beneficial, loss-of-function mutation in PHO13 (20). The mechanism of this improvement was 
later found to be, among others, transcriptional activation of genes in the pentose phosphate pathway (PPP) 
(21). The ALD6 gene was also deleted to prevent acetate accumulation and improve the efficiency of xylose 
fermentation (19). The present study aims to further optimize SR8 for enhanced xylose utilization rate and 
ethanol productivity. We hypothesize that even in an intensively engineered strain, iterative genome-scale 
screening may help identify new genetic targets. We recently developed RNAi Assisted Genome Evolution 
(RAGE) for iterative genome-scale engineering in yeast (22–24). In particular, a full-length cDNA library 
was constructed in the SR8 strain and processed into genome-wide modulation cassettes encoding both 
down-regulation and over-expression mutations. In each round of RAGE screening, modulation cassettes 
conferring the largest phenotypic improvement were integrated to create new parent strains for the next 
round to identify potential synergy between beneficial mutations (Figure 2.1). After three rounds of RAGE, 







Figure 2.1. Overall workflow of RNAi Assisted Genome Engineering. mRNA from SR8 strain is extracted 
and reverse transcribed to cDNA library. The library is then cloned in forward and reverse directions to 
generate over-expression and down-regulation libraries respectively. The libraries are then transformed in 
SR8 strain and screened on solid media with xylose as the sole carbon source. The largest colonies were 
identified and the improvement was confirmed and the best cassette was integrated into the genome of SR8. 
The new, improved strain was then used for the next round of RAGE and this cycle was repeated until no 
further improvements were observed. 
 
2.2. Materials and methods 
2.2.1. Strains, media and cultivation conditions 
S. cerevisiae strain SR8 (20) was a generous gift from Dr. Yong-Su Jin at the University of Illinois 
at Urbana-Champaign. Top10 chemical competent E. coli and NEB 10 electrocompetent E. coli (New 
England Biolabs, Ipswich, MA) cells were used for plasmid amplification and library construction, 
respectively. S. cerevisiae strains were cultivated in synthetic complete (SC) media with the appropriate 
dropout (0.17% Difco yeast nitrogen base without amino acids and ammonium sulfate, 0.083% amino acid 
dropout mix, 0.5% ammonium sulfate, 0.01% adenine hemisulfate and 2% glucose) or YPD medium (1% 
yeast extract, 2% peptone, and 2% glucose) for seed culture preparation, and plasmid amplification and 
isolation as appropriate. YPX 4% (1% yeast extract, 2% peptone, and 4% xylose) was used as the 
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fermentation media and the cells were grown in oxygen limiting conditions (30°C, 100 rpm in unbaffled 
flasks) to assess the xylose utilization rate and ethanol productivity. Growth media was supplemented with 
200 μg/mL of hygromycin B, or 200 μg/mL of G418 to select mutants harboring the plasmid or integrated 
cassettes as needed. The LiAc/SS DNA/PEG method was used for yeast transformation (25) and the cells 
were recovered for 4 hours after heat shock in YPD media when antibiotics were used as the selection 
marker. E. coli cells were grown in Luria Broth (LB) medium (Fisher Scientific, Pittsburgh, PA) with 100 
μg/mL of ampicillin or 25 μg/mL kanamycin to maintain the plasmid as appropriate. All restriction 
enzymes, Q5 polymerase, and the E. coli - S. cerevisiae shuttle vectors were purchased from New England 
Biolabs (Ipswich, MA) and all chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless 
otherwise specified. A summary of all strains used in this study is shown in Table 2.1. 
2.2.2. DNA manipulation and plasmid construction 
 
Zymoprep II yeast plasmid isolation kit (Zymo Research, Irvine, CA) was used to isolate plasmids 
from overnight S. cerevisiae cell cultures and a QIAGEN Plasmid Mini Kit (QIAGEN, Valencia, CA) was 
used to isolate plasmids from E. coli cells. RNA was extracted using a FastRNA™ SPIN Kit for Yeast (MP 
Biomedicals, Santa Ana, CA).  
The pITy3 plasmid designed for integration in the delta sites in S. cerevisiae using G418 as the 
marker was obtained from Dane Wittrup’s lab and was described elsewhere (26). Since the G418 marker 
was used for integration of the RNAi machinery, pITy3 was modified and the kanamycin marker was 
replaced with an ampicillin marker and the hygromycin resistance gene was inserted using the Gibson 
assembly method (27), allowing the construction of the new pITyH-amp plasmid. The best mutants from 
the first round of screening were amplified and inserted into the pITyH-amp plasmid using the DNA 
assembler method (28). The best mutants from the second round were inserted in the pRS406 plasmid using 
the DNA assembler method and integrated into the genome and grown on SC-URA agar plates as the 
selection pressure. Since both down-regulation and over-expression libraries were constructed on pRS416, 
the Uracil marker on the integrated strain was recovered by amplifying the URA3 gene from S. cerevisiae 
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CEN.PK strain genomic DNA and transforming it into the best mutant of the second round and plating the 
cells on SC-complete supplemented with 1 mg/mL of 5-fluoroorotic acid (5-FOA) to eliminate all the cells 
containing the functional URA marker (29). All the plasmids used and cloned in this study are summarized 
in Table 2.1. 
Strains or plasmids Name Characteristics 
Reference 
or source 
Strains    
SR8  SR7e3 ald6::AUR1-C pAUR_d_ALD6 (20) 
SR8+VPS13u MH1 SR8 pITy3H-Amp TEF1p-VPS13-PGK1t This study 
SR8+VPS13u+COX5Au MH2 SR8 pITy3H-Amp TEF1p-VPS13-PGK1t  - pRS406- 
TEF1p- COX5A-PGK1t 
This study 
SR8+VPS13u+MDH1u MH3 SR8 pITy3H-Amp TEF1p-VPS13-PGK1t  - pRS406- 
TEF1p- MDH1-PGK1t 
This study 
SR8+VPS13u+CDC11d MH4 SR8 pITy3H-Amp TEF1p-VPS13-PGK1t  - pRS406- 
TEF1p- CDC11Reverse -PGK1t 
This study 
SR8+ COX5Au MH5 SR8 pITy3H-Amp TEF1p-VPS13-PGK1t This study 
SR8+ MDH1u MH6 SR8 pITy3H-Amp TEF1p- MDH1-PGK1t This study 
SR8+ CDC11u MH7 SR8 pITy3H-Amp TEF1p- CDC11Reverse-PGK1t This study 
Plasmids    
pRS416-RAGE-FWD  pRS416-TEF1p-ccdB-PGK1t (30) 
pRS416-RAGE-REV  pRS416-TEF1p- ccdB -PGK1t  
pRS416-over-expression  pRS416-TEF1p-cDNA-PGK1t This study 
pRS416-down-
regulation 
 pRS416-TEF1p-cDNAreverse-PGK1t This study 
RNAi Integration  CEN.Ago.Dcr (30) 
pITy3   (26) 
pITyH-Amp  pITy3-Hygro-Amp This study 
 
Table 2.1. Strains and plasmids used in this study 
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2.2.3. Analytical methods 
Cell growth was determined by measuring the absorbance at 600nm from a Biotek Synergy 2 Multi-
Mode Microplate Reader (Winooski, VT). Xylose and ethanol concentrations were measured using a 
Shimadzu HPLC (Columbia, MD) with an Aminex HPX-87 column (Bio-Rad, Hercules, CA) and 
Shimadzu RID-10A refractive index detector. The column temperature was 65°C and the mobile phase for 
HPLC was 0.5 mM sulfuric acid solution with the flow rate of 0.6 mL/min. All data points shown were the 
mean of at least three replicates. 
2.2.4. Construction of genome-wide cDNA over-expression and down-regulation libraries 
The cDNA library was prepared using the In-Fusion SMARTer Directional cDNA Library 
Construction Kit (Clontech Laboratories, Mountain View, CA), following the manufacturer’s instructions 
and our previous work (22) with some modifications. In short, total RNA was extracted from the SR8 strain 
while grown on YPX4% media and harvested in the mid-log phase, the cDNA was reverse transcribed from 
the RNA and in the process, two 15 bp adaptor sequences of 5’-AAGCAGTGGTATCAA-3’ and 5’-
CGGGGTACGATGAGA-3’ were added to the different ends of the cDNA molecules to control the 
directionality of expression cassettes in the expression plasmids. The cDNA library was then cloned in two 
directions in two separate pRS416 plasmids under the expression of a PTEF1 promoter and a TPGK1 terminator 
using an In-Fusion cloning kit (Clontech Laboratories, Mountain View, CA). The assembled plasmid was 
then transformed into NEB 10 electrocompetent E. coli (New England Biolabs, Ipswich, MA) and 
recovered for 1 hour in SOC outgrowth media. Following the cell recovery, all the cells were plated on 50 
LB+Amp agar plates for amplification. Solid media was chosen for amplification to prevent the possible 
bias resulting from the different growth rates in liquid media due to size difference among the cDNA inserts. 
Roughly 106 independent colony forming units (CFU) were observed, resulting in roughly 100-fold 
coverage of yeast genes. The colonies were scraped off the plates and the plasmids were isolated using a 
QIAGEN Plasmid Midi Kit (QIAGEN, Valencia, CA). 
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To test the diversity of the libraries, both over-expression and down-regulation libraries were 
transformed into E. coli cells. Five colonies were picked from each of the over-expression and down-
regulation libraries and the harboring plasmids were amplified and purified. The isolated plasmids were 
sequenced by ACGT, Inc. (Wheeling, IL). Each of the 10 sequenced plasmids contained a different insert, 
suggesting efficient assembly and satisfactory diversity.  
The RNAi machinery constructed and reported in our previous studies (22, 23, 31) were integrated 
into the SR8 genome with G418 selection. The genomic DNA from the positive colonies was extracted 
using a Wizard® Genomic DNA Purification Kit (Promega, Madison, WI) and the integration of AGO1 and 
DCR1 was confirmed by PCR amplification.  
2.2.5. Library screening 
The down-regulation and over-expression libraries were transformed into the SR8 strain on 
selective synthetic media with xylose as the sole carbon source (SCX4%-URA). After 3 days, the 80 largest 
colonies were visually chosen and picked from each library of ~107 colonies and were grown in SC media 
with glucose. The overnight cultures were then used to inoculate 3 mL SC 4% xylose media with an initial 
optical density at 600 nm (OD600) of 0.1 and the growth was monitored using OD600 measurements. The 
fastest growers from both libraries were picked and the harboring plasmids were re-transformed into fresh 
SR8 cells to isolate the effect of the genes from possible adaptation and confirm the positive effect of 
manipulation of the genes on cell growth. The top mutants were then identified and the over-expression or 
down-regulation gene cassettes responsible for the superior growth were integrated into the SR8 genome. 
The cells were then inoculated in SCD media with the appropriate drop-out or antibiotic selection. The 
overnight cultures were then inoculated in 10 mL YPX 4% xylose media with an initial OD600 of 1 without 
any antibiotic supplementation and the ethanol production and xylose utilization were measured every 12 
hours. Since antibiotic supplementation hinders the growth, and since the genes were already integrated in 
the genome, it was assumed that the integration was stable enough for the short period of cell growth given 
the stable nature of the integrated cassette (32). 
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2.2.6. Estimation of down-regulation and over-expression efficiencies 
 To estimate the down-regulation and over-expression efficiency, quantitative qPCR was 
performed. First, the total RNA was extracted from the mutant strains and control SR8 strain grown on 
YPX4% at mid-log phase using a RNeasy mini kit (QIAGEN, Valencia, CA). Reverse transcription was 
performed on 1µg of RNA to produce first strand cDNA using an iScript cDNA synthesis kit (BioRAD, 
Hercules, CA). For each cDNA sample, the primers for the target gene as well as ALG9 gene were 
included as internal control in six replicates for each. Quantitative PCR reaction was performed using a 
QuantStudio 7 Flex Real-Time PCR System with Power SYBR Green PCR Master Mix (ThermoFisher 
Scientific).  
2.3. Results 
2.3.1. Screening of down-regulation and over-expression libraries 
The over-expression and down-regulation libraries were separately used to transform the SR8 
strain. The transformed cells were screened on media with xylose as the sole carbon source. The best 
performing mutants from the first round of RAGE were identified. Over-expression of Vacuolar Protein 
Sorting 13 (VPS13) and down-regulation of Cell Division Cycle 11 (CDC11) were found to be the most 
beneficial changes for improved xylose utilization and ethanol productivity. Since VPS13 was superior to 
CDC11 in improving the xylose utilization and ethanol productivity, the SR8 with VPS13 integrated in its 
genome (named MH1 hereafter) was chosen for further optimization. 
The second round of RAGE was then performed where the down-regulation and over-expression 
libraries were transformed into the SR8 with VPS13 and the same screening protocol was repeated. Down-
regulation of CDC11 and over-expression of Cytochrome c Oxidase (COX5A) and malate dehydrogenase 
1 (MDH1) genes were found to improve xylose utilization and ethanol productivity the most. It was notable 
that down-regulation of CDC11 was found in both the first and second rounds of RAGE, showing its 
significance in xylose utilization. The third round of RAGE was performed with the strain harboring VPS13 
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and CDC11 (MH2), but after re-transformation, none of the mutants were superior in xylose utilization and 
therefore no further rounds of screening were performed. 
2.3.2. Analysis of the best mutant 
After three rounds of RAGE, the genes responsible for faster xylose utilization were identified and 
further analyzed. A comparison of xylose utilization and ethanol productivity between the SR8 and the best 
mutant of each round is shown in Figure 2.2. Ethanol productivity and xylose utilization rate in the best 
mutant were improved by 45% and 29%, respectively, compared with the SR8 strain with no modifications. 
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Figure 2.2. Xylose utilization and ethanol production in a) SR8; b) MH1; c) MH2.  
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To confirm the effectiveness of down-regulation and over-expression, the expression level of the 
mutants was estimated using quantitative PCR (Figure 2.3). It was observed that the down-regulation and 
over-expression was successful. The expression level was considerably reduced in strains with down-
regulation cassette and increased with strains with over-expression cassettes integrated. 
 
 
Figure 2.3. Quantitative PCR analysis of the down-regulated and over-expressed gene targets. The 
expression levels compared are CDC11 in SR8 and MH4, COX5A in SR8 and MH2, MDH1 in SR8 and 
MH3 and VPS13 in all the strains, respectively.  
 
A one-tailed, two-sample unequal-variance t-test was applied, and it was observed that the 
improved xylose utilization rate (29%) and ethanol productivity (45%) were statistically significant with a 
p-value < 0.01 for six biological replicates from two experiments. The change in the ethanol yield was not 
statistically significant, suggesting that these mutants grew faster but were not necessarily yield more 
ethanol. This was not unexpected since the screening was based on the growth rate rather than final ethanol 
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production. The comparison between the SR8 strain and the best mutant in the first round and top 3 mutants 
in the second round is shown in Table 2.2. 
Growth Media  SR8 MH1 MH2 MH4 MH3 
YPX 4% rxylose 1.16±0.05 1.37±0.03 1.40±0.01 1.50±0.03 1.46±0.02 
rxylose* 0.73±0.09 0.85±0.07 0.88±0.05 0.93±0.03 0.92±0.02 
Yethanol 0.29±0.03 0.29±0.04 0.29±0.05 0.32±0.06 0.32±0.04 
Pethanol 0.33±0.02 0.40±0.03 0.42±0.02 0.48±0.04 0.44±0.03 
Pethanol* 0.22±0.03 0.27±0.02 0.28±0.03 0.32±0.02 0.29±0.03 
SCX 4% rxylose* 0.56±0.03 0.66±0.04 0.69±0.02 0.76±0.03 0.75±0.04 
Yethanol 0.29±0.01 0.30±0.02 0.28±0.04 0.33±0.06 0.31±0.04 
Pethanol* 0.17±0.01 0.22±0.03 0.24±0.03 0.26±0.04 0.24±0.02 
 
Table 2.2. Fermentation profiles of SR8 and SR8 with over-expression and down-regulation of beneficial 
genes found in this study. The fermentation was performed in YPX 4% and oxygen limited condition (100 
rpm). Parameters in this table are:  rxylose, xylose consumption rate (g/L/h), Yethanol, ethanol yield (g ethanol/g 
sugars) and Pethanol, ethanol productivity (g ethanol/L/h).  
 
2.3.3. Characterization of the improved mutants 
To examine the dependence of growth on the carbon source, the growth of the same strains were 
tested in glucose and galactose conditions and it was found that when grown on glucose, all the mutants 
showed a similar growth rate. However, all the other mutants grew faster than SR8 on galactose media 
(Figure 2.4). S. cerevisiae was evolved to grow on glucose and it is expected that these genetic 
modifications were unable to improve its growth in glucose media. However, the improved growth on 
galactose media may be indicative of glucose repression and regulation that has been observed repeatedly 
in the literature (33–35).  
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a       b 
Figure 2.4. Growth curve of the best mutants in media with a) galactose and b) glucose as the sole carbon 
source. 
To observe its effect on growth, each of the genes from the second round were integrated into the 
genome and their phenotypes were compared to that of SR8 with no modifications (Figure 2.5). All of 
them showed improved xylose utilization and ethanol productivity, but when co-expressed with VPS13, 
they showed faster growth, which suggests a synergistic or additive effect between these genes.  
A one-tailed, two-sample unequal-variance t-test was applied, and it was observed that the 
improved xylose utilization rate (29%) and ethanol productivity (45%) were statistically significant with a 
p-value < 0.01 for six biological replicates from two experiments. The change in the ethanol yield was not 
statistically significant, suggesting that these mutants grew faster but did not necessarily yield more ethanol. 
This was not unexpected since the screening was based on the growth rate rather than final ethanol 
production. The comparison between the SR8 strain and the best mutant in the first round and top 3 mutants 
in the second round is shown in Table 2.2. The statistical significance of the improvements of best mutants 
from the second round over SR8 strain (Figure 2.5) was evaluated and summarized in Table 2.3 using a 




 Xylose Utilization Ethanol Production 
Time (h) MH6 MH7 MH5 MH6 MH7 MH5 
12 p<0.01 p<0.01 p<0.01 p<0.01 p<0.05 p<0.01 
18 p<0.01 p<0.01 p<0.01 p<0.01 p<0.01 p<0.05 
24 p<0.01 p<0.01 p<0.05 p<0.001 p<0.05 p<0.001 
30 p<0.01 p<0.01 p<0.05 p<0.01 p<0.01 p<0.05 
36 p<0.001 p<0.001 p<0.05 p<0.05 p<0.05 p<0.05 
 
Table 2.3. Calculated p-value using a two-sample unequal-variance t-test for evaluating the statistical 
significance of the improvements of best mutants of the second round over SR8 strain at different time 
points. The data is obtained by performing experiments with three biological replicates. 
 
 












































a       b 
Figure 2.5. Xylose utilization (a) and ethanol production (b) in SR8 strain and all the mutants identified 
in the second round of RAGE.  
2.4. Discussion 
In this study, RAGE was used to improve an extensively engineered yeast strain for xylose 
utilization. Using a genome-wide library encoding both over-expression and down-regulation mutations, 
four gene targets were found to improve the xylose utilization rate in S. cerevisiae.  Combining these genetic 
manipulations, 29% and 45% improvement in xylose utilization rates and ethanol productivity were 
observed, respectively. It was found that over-expression of VPS13, MDH1, and COX5A, as well as down-
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regulation of CDC11 improved xylose utilization. These findings provide valuable insights into the 
bottlenecks of xylose utilization.  
Although the exact reason for these genes to be beneficial to xylose utilization rate has yet to be 
elucidated, it is possible to speculate potential mechanisms resulting in the favorable changes of this 
phenotype from functions previously described in the literature. The proposed function of these genes is 
briefly described in Table 2.4.  Jin and co-workers did a genome-wide expression analysis under different 
carbon sources and oxygen level conditions and found that growth in xylose resulted in more than two-fold 
up-regulation of many genes in the TCA cycle and respiration pathways (10). Two of the over-expression 
genes found in our study (COX5A and MDH1) are in those categories. We speculate that since these genes 
are over-expressed in xylose media, they may have an important role in xylose utilization which makes 
them reasonable targets for our genome wide library screening. It was shown that the MDH1 gene, for 
example, was expressed twice as much under xylose assimilating conditions as when it was grown on 
glucose. We hypothesize that the over-expression of MDH1 is improving xylose utilization by bypassing 










Gene Description (www.yeastgenome.com) 
VPS13 Protein involved in prospore membrane morphogenesis; peripheral membrane 
protein that localizes to the prospore membrane and at numerous membrane contact 
sites; involved in sporulation, vacuolar protein sorting, prospore membrane 
formation during sporulation, and protein-Golgi retention; required for 
mitochondrial integrity; contains a PH-like domain; homologous to human CHAC 
and COH1 which are involved in Chorea-acanthocytosis and Cohen syndrome, 
respectively 
CDC11 Component of the septin ring that is required for cytokinesis; present at the ends of 
rod-like septin hetero-oligomers; C-terminal extension is important for recruitment 
of Bni5p to the mother-bud neck, which in turn is required for Myo1p recruitment 
and cytokinesis; septin rings at the mother-bud neck act as scaffolds for recruiting 
cell division factors and as barriers to prevent diffusion of specific proteins between 
mother and daughter cells 
COX5A Subunit Va of cytochrome c oxidase; cytochrome c oxidase is the terminal member 
of the mitochondrial inner membrane electron transport chain; Cox5Ap is 
predominantly expressed during aerobic growth while its isoform Vb (Cox5Bp) is 
expressed during anaerobic growth; COX5A has a paralog, COX5B, that arose from 
the whole genome duplication 
MDH1 Mitochondrial malate dehydrogenase; catalyzes interconversion of malate and 
oxaloacetate; involved in the tricarboxylic acid (TCA) cycle; phosphorylated 
 
Table 2.4. Known gene functions for beneficial over-expression and down-regulation targets 
 
Many reports have suggested that aeration and oxygen supply can greatly affect xylose 
consumption (5, 10, 36–38). Fundamental differences in oxygen requirements between growth in xylose 
and glucose have been observed in fungi and oxygen starvation studies showed induction of cell death on 
xylose but not glucose in the yeast strain Candida shehatae (36). These results emphasized the importance 
of aeration and electron chain transport in xylose utilization and hence showed the relevance of COX5A. In 
another study, it was also observed that COX5A was expressed 3.5 times more under xylose utilizing 
conditions (5). With ample evidence on the importance of aeration found in the literature, it is not 
unexpected that over-expression of COX5A resulted in improved xylose utilization. 
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To the best of our knowledge, there has been no report associating CDC11 and VPS13 with better 
growth on xylose. However, CDC11 was observed to be expressed less in media with xylose as the carbon 
source compared to glucose (39). In S. cerevisiae, CDC11 is one of the main septins that by introducing a 
diffusion barrier between the mother and daughter cells in the bud neck, recruits other proteins to the site 
of cytokinesis (40). CDC11 deficient cells are usually inviable or have a very slow growth rate (41) and 
ΔCDC11 strains were shown to be inviable on glucose medium at room temperature whereas they were 
able to be recovered on galactose medium (42). This shows the carbon source dependence of the effect of 
this gene in the cell and may be related to its effect on xylose utilization rate.  Detecting CDC11 as a target 
also emphasizes the power of down-regulation over knock-out since CDC11 is an essential gene and the 
knock-out strain would not have been viable and thus not found in the screening. 
The exact mechanism of over-expression of VPS13 contributing to xylose utilization is unknown. 
Both VPS13 and CDC11 were reported to affect morphology and cell growth (43). Since the growth rate in 
glucose is different from xylose, tuning these genes may be beneficial for xylose utilization since they play 
a role in the timing of cell division. VPS13 was also reported to be important for the delivery of proteins to 
and from the vacuole (43), which may explain why this gene effects xylose utilization.  
It is noteworthy that the SR8 strain has previously been extensively engineered and optimized and 
therefore is difficult to further improve as it harbors many of the already known beneficial genetic 
manipulations. RAGE can be a tool for improving the phenotype even when all other tools have been 
exhausted. The growth rate did not improve after 5 rounds of adaptation on SR8 Figure 2.6, but RAGE 
could still improve the xylose utilization rate by 29%. 
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Figure 2.6. Five rounds of adaptation did not improve xylose utilization. The initial OD for each round was 
1 and the cells were grown in YPX 4% media. 
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Chapter 3: Machine Learning-driven Fully Automated Pathway Optimization 
 
3.1. Introduction 
Microbial biosynthesis of fuels and chemicals has always been of great importance due to the 
promise of inexpensive and environmentally friendly chemical synthesis. After the discovery of the 
biochemical pathway for biosynthesis of a value added chemical in microbial hosts, the daunting task of 
increasing the yield and productivity should be tackled. This step is crucial in the successful and widespread 
use of the biochemical pathway to compete with its potential petrochemical or plant-based counterparts. 
One of the reasons for low productivity and yield is flux imbalance of the biosynthetic pathway (1–3). This 
is especially important in pathways with multiple reactions where their intricate balance can be difficult. 
Fine-tuning the flux of each step in a pathway and its optimization has been shown to be a very effective 
strategy for increasing the total flux in a variety of different cases (4–7). An imbalanced pathway can 
decrease the general flux by causing metabolic burden by excessive expression of enzymes or producing 
excess amounts of potentially toxic intermediates in the cell (8). The excess amounts of intermediates can 
also result in flux being diverted to side reactions (9), as well as intermediates being lost to the media 
through the cell membrane (10). 
In most cases, pathway optimization is challenging due to biological complexity and the myriad of 
unknown interactions in cells. The abstraction of this problem can be represented by an expression-
production landscape where the maximum flux is achieved by a certain expression level of each of the 
genes in the pathway. Finding the maximum point will then become an optimization problem which has 
been widely studied in other fields such as computer science (11–14). The objective of this optimization 
will be to evaluate some of the points and find the maximum of this black-box expression-production 
landscape. 
There have been many studies to perform pathway optimization and find the maximum of this 
landscape. One of the most intuitive and effective approaches is random search where millions of random 
points in the expression-production landscape are evaluated and the best one is assumed to be close to the 
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global maxima. This method has been shown to be extremely effective where a large number of points can 
be evaluated with relatively low-cost i.e. a high-throughput screening method is available (6, 15, 16). 
However, in the absence of high-throughput screening, evaluating millions of different points in a 
random search is prohibitively expensive and practically impossible. To perform the optimization in these 
cases, the number of points evaluated should be decreased to a manageable number. One successful method 
is modular optimization where different parts of the pathway, i.e. modules, are optimized separately and 
then the relative expression level of each module is fine-tuned to optimize the total flux of the pathway (5, 
17). This objective has also been achieved by using regression (18) and search with system level kinetic 
modelling where a smaller set of points are evaluated and the results are given to a model and the maximum 
is predicted (7). These methods have achieved impressive results and shown a great correlation between 
predicted and measured values. However, since the data given to the regression model is randomly 
distributed in the expression-production landscape, the model has been trained well in some areas and not 
so well in others. This is significant since the areas where higher values are expected are of especial interest 
to us and the low points on the landscape have little practical importance. Moreover, sampling more from 
the areas of interest and less from those valleys reduces the time and cost of the overall pathway 
optimization workflow. 
Instead of evaluating all the points at once, the same objective can be achieved by iterative 
evaluation of a smaller number of points. This concept of “Active Learning” has been extensively used in 
other fields (19) and is the underlying principle of the Design, Build, Test and Learn cycle (20). There are 
many successful examples of active learning where the objective is to learn a specific function with as little 
evaluations as possible (21, 22). As evident from the common theme of these applications, active learning 
is especially useful where data acquisition is very expensive and we either do not want to ask many 
questions from a user or perform many costly experiments. 
 Here we used Bayesian optimization as the active learning algorithm to drive the experimental 
procedure. The algorithm evaluates a few points on the expression-production landscape and trains a 
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probabilistic model, Gaussian process, on that data obtained from those evaluations. Gaussian process 
assigns an expected value and confidence level to each one of the unevaluated points on the expression-
production landscape. An acquisition function then picks the next points to be evaluated based on the 
probabilistic model to minimize the total number of experiments required before finding the maximum of 
the landscape. By reducing the confidence of the model on the points that have been evaluated, an error is 
also incorporated in the algorithm which makes it ideal for potentially noisy data like biological 
experiments. The predictive model used in this work, Gaussian process, has been previously used in protein 
engineering of membrane proteins (23) and was also coupled with the Bayesian optimization algorithm for 
improving the thermo-stability of chimeric cytochrome P450 enzymes and achieved higher thermo-stability 
than previously achieved by rational design or directed evolution (24). 
The lycopene production pathway was chosen as a proof of concept due to the ease of 
quantification. Because of the efficacy and sensitivity of this assay, it has been widely used in various proof 
of concept studies in pathway and protein engineering (25). Carotenoids, and especially lycopene have also 
been considered high-value chemicals with antioxidant properties (26).  Here, DNA assembly, cell 
transformation, cell culture, lycopene extraction and quantification were performed using a fully-automated 
workflow on Illinois Biological Foundry for Advanced Manufacturing (iBioFAB) (20, 27, 28). By 
integrating the machine learning algorithm with iBioFAB, the design, build, test and learn (DBTL) cycle 
was closed and we could fully harness the power of a fully-automated robotic platform where the robot 
designed and performed the experiments, analyzed and learned from the data and decided on the next round 
of experiments to perform to achieve the objective function, high lycopene production, with performing 
only a few experiments.  
There have been a few successful examples where a fully-automated platform performed 
experiments and generated hypotheses based on the results and verified or nullified them in iterative 
experiments (29–31). However, these methods have been mostly focused on generating the hypothesis 
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whereas in this study, hypothesis generation was coupled with adaptive sampling to reduce the number of 
experiments for achieving the goal. 
Here we also introduce a class of models for the smart design of biological experiments where data 
acquisition is noisy and expensive. The model directs the experiments where the objective is finding the 
optimum value rather than learning about the landscape by performing as few experiments as possible. The 
effectiveness of this method was demonstrated in our pathway optimization. We also demonstrated, 
RoboScientist, the first fully automated active learning-driven pathway optimization workflow where the 
active learning algorithm was not only used to generate hypothesis on the biological landscape, but also 
actively guided the execution of the experiments that are the most informative or important for the objective 
function designed for it, reducing the cost and time to find the optimum. Although this active learning 
algorithm is especially powerful when combined with fully-automated experimentation where it can drive 
the automated platform to perform the experiments in a relatively autonomous fashion, it can also be used 
to drive experiments in a smaller scale and less automatic workflows in semi-automatic or manual setup. 
3.2. Materials and methods 
3.2.1. Strains, media and cultivation conditions 
 DH5α and BL21(DE3) E. coli (New England Biolabs, Ipswich, MA) cells were used for making 
chemically competent cells using a Mix & Go E. coli Transformation Kit (Zymo Research, Irvine, CA) for 
plasmid amplification and lycopene production respectively. E. coli cells were grown in Luria Broth (LB) 
medium (Fisher Scientific, Pittsburgh, PA) supplemented with 50 μg/mL of spectinomycin (Spec) or 25 
μg/mL kanamycin (Kan) to maintain the plasmid or 0.5 mM isopropyl--D-thiogalactoside (IPTG) for 
induction as appropriate. Antibiotics and IPTG were purchased from Gold Biotechnology (St. Louis, MO). 
DH5α E. coli cells, as well as BL21(DE3) starter cell cultures, were grown at 37°C, but BL21 (DE3) cell 
cultures for lycopene production were grown at 28°C, the optimum growth temperature for lycopene 
production (32, 33). The dry cell weight (DCW) was calculated from the OD600 using the previously 
reported conversion rate (34). 
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3.2.2. DNA manipulation and plasmid construction 
 To generate the T7 promoter (T7p) variants with different expression levels, the region attributed 
to its strength (35) was mutated by using T7p-mut-3N and T7p-mut-6N primers with three to six random 
bases respectively. These primers were used for amplifying the eGFP gene with the T7 terminator (T7t) 
primers to create a library with a variety of different T7 promoter strengths. The resulting T7p-mut-eGFP-
T7t DNA fragment was cloned into the pET26 (b) backbone as described by Freestone and co-workers (36). 
The resulting library was then transformed into BL21(DE3) competent cells and 192 colonies were 
randomly picked and grown overnight at 37°C. The next day, 900 μL LB+Kan was inoculated with 10 μL 
of the seed culture and was incubated at 37°C. After 3 hours, 100 μL of LB+Kan with 5 mM IPTG was 
added to the cell culture and it was incubated at 28°C. After 4 hours, eGFP fluorescence (488 nm 
excitation/509 nm emission), as well as OD600, were measured and 24 different promoters were chosen 
for further characterization. Two Ribosome Binding Site sequences were designed using the RBS library 
calculator (37) for translation regulation and were combined with the identified promoters to evaluate their 
strength. These promoters were then used to clone the T7-mut-RBS-eGFP-T7t expression cassette. 12 of 
these promoters that exhibited a wide range of strengths were chosen as a promoter library for transcription 
regulation.  
A QIAGEN Plasmid Mini Kit (QIAGEN, Valencia, CA) was used to isolate plasmids from E. coli 
cells and Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA) was used for gel purification. 
All restriction enzymes, Q5 polymerase, Gibson Assembly master mix components and the E. coli shuttle 
vectors were purchased from New England Biolabs (Ipswich, MA) and all chemicals were purchased from 
Sigma-Aldrich (St. Louis, MO) unless otherwise specified. 
 
3.2.3. Golden Gate assembly 
 A Golden Gate assembly method was used to assemble the lycopene pathway with different 
expression levels of each gene. First, the pSPE plasmid was digested with AFIII and XbaI restriction 
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enzymes. After digestion, two complementary oligos containing Golden Gate optimized overhangs reported 
to have high efficiency (27), as well as a T7 promoter, terminator, and EcoRV recognition site were 
annealed, phosphorylated and cloned between the cut sites to generate the backbone for CrtE, CrtB and CrtI 
expression cassettes. A RBS was added to each of the CrtE, CrtB and CrtI genes using PCR amplification 
and the T7 promoter was added in another step of PCR reaction, creating a T7p-mut-RBS-gene-T7t 
construct. The backbone plasmid was then amplified, digested with EcoRV and each of the CrtE, CrtB, and 
CrtI genes with different RBS/T7 promoter strengths were cloned using the Gibson assembly method (38). 
The T7 promoter and terminator were used as the homology arms for Gibson assembly using commercial 
NEBuilder HiFi DNA Assembly Cloning Kit (New England BioLabs, Ipswich, MA). The 72 assembled 
plasmids were then amplified in E. coli and the inserts were confirmed by PCR amplification. The pET26b 
plasmid was used as the receiver for the lycopene biosynthetic pathway. The Golden Gate overhangs as 
well as the BsaI sites were placed on two complementary oligonucleotides resulting in a short DNA 
fragment with sticky ends after annealing and phosporylation. pET26b plasmid was digested with XhoI and 
SphI restriction enzymes and ligated to the DNA fragment containing overhangs to construct the backbone 
for lycopene production pathway. 
 The 73 assembled parts containing 72 inserts and 1 backbone were amplified in E. coli and purified. 
The concentration of the backbone was set at 30 ng/μL and the concentration of the rest of the parts was 
adjusted to the same molar concentration.  Each 20 μL Golden Gate reaction consists of 100ng from each 
of the backbone, CrtE, CrtB and CrtI, 10 units of BsaI restriction enzyme, 100 units T4 DNA ligase, 2 μL 
of CutSmart buffer and 0.75μl of ATP (25mM). After the Golden Gate reaction, 5 μL of nuclease master 
mix (2.5 units of BsaI, 2.5 units of plasmid safe nuclease (Illumina, San Diego, CA) , 0.5 μL CutSmart 
buffer and 1μL ATP (25mM)) was added to the reaction to linearize any undigested backbone and remove 
all the linear parts from the mixture. The Golden Gate and plasmid safe master mix protocols have been 
adopted from our previous work (27) with some modifications but the thermocycling protocol remains 
unchanged. To test the efficiency and fidelity of the Golden Gate assembly, 24 reactions using each of the 
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72 parts were done at least once and 4 colonies from each reaction transformant were selected and the all 
the assemblies were confirmed to be correct.  
3.2.4. Lycopene extraction and quantification 
Lycopene can be extracted by organic solvents and quantified calorimetrically by measuring the 
absorbance at 470nm (25). This assay is highly sensitive and has been reported to quantify the amount of 
lycopene with submiligram accuracy (39, 40). The most common lycopene extraction and quantification 
method involves resuspension and incubation of the cells in acetone (41–43). Since acetone is extremely 
volatile and dissolves the glue seals and some of the other consumables, it is not ideal for use in the 
automation system. Therefore, four other organic solvents reported in previous publications (32, 44) were 
tested for efficacy in lycopene extraction. The most effective extraction method that is compatible with the 
high-throughput system was DMSO. E. coli cell cultures were spun down and the supernatant was removed 
from the culture. The cells were then resuspended in 300 μl of DMSO and were incubated for 30 minutes 
at 37°C at 1000 rpm. After the incubation, the cell-DMSO mixture was spun down at 3000rpm for 10 
minutes and 200 ul of the supernatant was aspirated and the absorbance at 470 nm was measured and 
correlated to lycopene production. 
3.2.5. Full automation of assembly, transformation, cultivation and extraction 
The iBioFAB platform (28) was used to automate the assembly of DNA parts for the lycopene 
pathway, transformation, cell cultivation and lycopene extraction. The overall workflow of the experiments 
is shown in Figure 3.1. First, the parts to be assembled are generated by the machine learning algorithm 
and given to the previously described (27) script generator to generate the pipetting routs for the Tecan 
liquid handler. The DNA mixture plates were then spun down, mixed with Golden Gate master mix and 
moved to the thermocycler for the Golden Gate reaction. After 30 cycles of digestion and ligation in Golden 
Gate assembly, Plasmid Safe master mix was added to the mix followed by 30 minutes of digestion with 
BsaI and plasmid safe nuclease. The plasmid safe treated Golden Gate assembly product was then 
transformed in BL21(DE3) E. coli competent cells and plated on LB agar plates and moved off the deck 
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for incubation. The plates were incubated at 37°C overnight and four single colonies were picked from each 
of the plates using the Pickolo colony-picker (SciRobotics, Israel) and inoculated in 1ml of LB+Kan media. 
The seed culture was grown overnight and 50μl of the culture was added to 750 µl fresh LB+Kan media 
and incubated at 37°C. After two hours, 200 μL of LB+Kan+2.5 mM IPTG was added to the culture and 
the induced cells were incubated at 28°C for 24 hours for maximal production(32). The OD600 was measured 
and the cells were then pelleted and resuspended in DMSO and incubated at 37°C for 30 minutes for 
lycopene quantification. 
 
Figure 3.1. The overall fully automated pathway optimization workflow. The machine learning 
algorithm picks the plasmids to be assembled returns the list to iBioFAB to perform the assembly. The 
assembled products are then transformed and four single colonies are isolated for lycopene 
quantification and OD measurement. The resulting data is then given to the machine learning algorithm 
to pick the next set of points to be evaluated. 
 
3.3. Results 
3.3.1. Bayesian optimization for navigating the expression-production landscape 
Since the expression-production landscape is very similar to a black-box function where not much 
is known about the behavior or where the maximum is prior to testing, we set to use algorithms developed 
by Snoek and co-workers (45) to solve such problems. Bayesian optimization (46) is a powerful method 
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that has been shown to outperform many algorithms in optimizing challenging functions (47). In short, 
Bayesian optimization constructs a probabilistic model and uses this model to make decisions on where to 
evaluate to minimize the total number of evaluations. The algorithm takes the expected outcome of each 
evaluation as well as the confidence on this expected outcome to find the next point to evaluate. By taking 
confidence levels on each point into account while trying to find the maximum with as few evaluations as 
possible, this algorithm is ideal for cases where data acquisition is expensive and potentially noisy. Since 
performing experiments is both expensive and includes inevitable error, we found this approach to be ideal 
for our system.  Bayesian optimization uses the probabilistic model and assumes a “prior” knowledge about 
a certain function and updates that prior knowledge based on the new information using the Bayes rule and 
calculates the “posterior,” hence the name Bayesian optimization. To use this algorithm, two main functions 
must be chosen, a probabilistic model or “surrogate function” to make assumptions about the expression-
production landscape given the available data and an acquisition function to suggest which points to be 
evaluated next to minimize the number of evaluations. 
 To use Bayesian optimization for the expression-production landscape, we sought to use the 
Gaussian process (GP) probabilistic model to assign an expected value and confidence level to all the 
unevaluated points. The Gaussian process (GP) was chosen due to its flexibility and broad applications (24, 
48, 49). GP assigns a mean and variance to each point in the landscape and as more points are evaluated, 
the mean and variance are updated accordingly. The mean and variance show predicted values for those 
points and the confidence on those predictions respectively. Figure 3.2 shows a mean and variance 
predicted by a Gaussian process where the dashed lines represent the mean and the grey region shows 
confidence intervals with two standard deviations from the mean. When only one point is evaluated (Figure 
3.2a), most of the landscape is unknown and the confidence interval and mean have changed slightly around 
the evaluated point. However, with three (Figure 3.2b) and five (Figure 3.2c) points evaluated, the mean 
gets closer to the function and the variance decreases. It is noteworthy that the variance gets smaller in the 
regions closer to the points that are already evaluated and is at a minimum at those points. In experimental 
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settings, the variance around the points that are evaluated can be adjusted based on the error from the 
experiment.   
 
   A      B 
 
C 
Figure 3.2. Demonstration of mean and variance of a Gaussian process estimating a sine function. The 
dashed lines show the mean and the grey areas two standard deviations from the mean. With only one point 
evaluated (A), the mean is only slightly adjusted, and the variance has changed around the point evaluated. 
With two (B) and five (C) points evaluated, the mean gets closer to the sine function and the confidence 
level increases across the landscape with the most change being in the vicinity of the evaluated points. 
  
Acquisition functions are the second major decision to be made for using Bayesian optimization. 
These functions drive the experimental direction and enable the user to find the maximum with fewer 
evaluations. Given the expected value and confidence on that value, we are faced with a trade-off between 
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exploration and exploitation. If only the points that are expected to have the largest values are tested next, 
we risk only finding local maxima since the area next to the global maxima may be unexplored in the first 
evaluated points. However, if we only evaluate points where we have little confidence on the expected 
value, although we learn more about the landscape, in most cases these expensive experiments are wasted 
on increasing the confidence level on low-producing regions rather than focusing on finding the maximum. 
 Several algorithms are suggested for balancing the trade-off between exploration and exploitation 
and the maximum of acquisition function represents an automatic trade-off between these two factors. One 
of the common acquisition functions is Upper Confidence Bound (UCB) where the mean and a multiplier 
of variance are added together, and the maximum of this function is a relatively good point for the next 
evaluation since it has a high expected value or variance or both. However, the value of the multiplier is 
rather arbitrary, is case dependent and has to be fine-tuned for each system or even changed adaptively after 
each evaluation in the same system (24, 50, 51). 
 Another commonly used and rather more satisfying acquisition function is Expected Improvement 
(EI) (50, 45) where the algorithm estimates how much improvement over the current best is expected from 
each one of the points, and samples the point with the highest expected improvement. This function 
elegantly balances the exploration and exploitation trade-off by using the already trained GP and finds the 
point that provides the highest expected improvement. This algorithm was chosen as the acquisition 
function in this work. 
3.3.2. Modifications for compatibility with biological experiments 
 As described before, Bayesian optimization relies on sequential experiments. Each time a point is 
evaluated, the result is given to the algorithm to update the GP and find the next point to be evaluated using 
the acquisition function. However, it is more efficient to perform some experiments in parallel in sequential 
batches as to reduce the number of total rounds of the experiment. Fortunately, a variation of Bayesian 
optimization has been recently developed for multi-core parallel processing applications. This algorithm 
can handle multiple “pending” evaluations and can get the result of any of the pending evaluations at any 
given time and return the next point to be evaluated (45). In short, the algorithm considers likely outcomes 
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for each of the pending points and calculates the acquisition functions based on the all possible outcomes. 
Naturally, as the number of pending points increases, finding the next pending point gets more 
computationally intensive given the exponential growth of the number of possible scenarios. However, 
given the powerful computing machines available, this is of low concern, especially if compared to the 
biological experiments’ timescale. This method was used to drive the direction of our experiments and one 
batch of points was chosen and evaluated in each round and the result was given to the algorithm to generate 
the next batch of points to be evaluated.  
If there was no error in the experiments, which is the case for evaluation of mathematical functions, 
the confidence level around the points that are already evaluated would be very high and the variance would 
be almost zero. However, since the result of all experiments contain some error and is far from a perfect 
mathematical evaluation, the confidence in the results was adjusted so the program expects an error in the 
evaluations and adjusts the mean and variance for all the points accordingly.  
3.3.3. Evaluation of the Bayesian optimization 
 To test Bayesian optimization with GP, we defined a 2-dimensional toy model and tried to find the 
maximum value by sequential sampling (Figure 3.3). The model was deliberately chosen to have multiple 
peaks and local optima to test whether the optimization algorithm can indeed find the global maximum. 
The algorithm was able to find the maximum and the exploration and exploitation trade-off can be inferred 
from the sampling order.  
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Figure 3.3. Testing bayesian optimization by trying to find the maximum of a 2 dimensional function. 
The algorithm evaluated 12 points before finding the maximum. The order in which each point is 
evaluated shown on the graph. 
 
 
 We then sought to test the optimization method with a similar 4-dimensional model with three 
inputs and one output to better simulate the experimental conditions in pathway optimization. The search 
perimeter was set to be 1-24 for each of the inputs and the maximum of the function was set to be 9 (y= 
f(x1, x2, x3) | xi  {1, 2,…, 24}, f max = 9) and the Bayesian optimization was able to find the maximum value 
of 9 by only evaluating 12 points out of all possible 13,824 points. We then sought to compare this active 
learning strategy with random sampling and a passive learning regression based model, Exterior Derivative 
Estimation (EDE) described in previous publications (18, 52). We found that although this type of model 
shows impressive predictive capability, especially given that all the data has been acquired at once, even 





Number of points Maximum Predicted Real value Maximum 
16 6.9 8.2 9 
48 7.4 8.4 9 
96 7.4 8.4 9 
192 7.4 8.4 9 
 
Table 3.1. Evaluating state of the art regression model on a 4-dimensional function. EDE regression 
model was trained on a different number of randomly picked points and the point with best expected 
value was predicted by the model and was compared to the real value for that point.  
 
 We then tested the Bayesian optimization method by adding 10% error to the output value of 
function evaluation to better simulate the real experimental setup and observed that the algorithm could still 
find the maximum of the function, but the number of evaluations was increased from 12 to 18. This shows 
that, as expected, error makes the optimization more difficult, but the Bayesian optimization algorithm can 
adjust for it and still find the maximum.  
 We then set to optimize the number of points evaluated in each round, with a trade-off between the 
experimental cost and time. As the size of each batch increases, the cost of experiments increases as well, 
however, the number of total rounds of experiment, hence the time spent on the entire project decreases. 
The batch size can also be adjusted from round to round and be decreased in the later rounds as the focus 
shifts from exploration to exploitation. However, for the sake of simplicity, we used a constant batch size. 
The batch sizes are also constrained by experimental conditions especially given the standard 96 well format 
for high-throughput biological experiments. A few batch sizes were simulated on the test model described 
previously while including 10% error, and even with these constraints it was found that batch sizes larger 
than 46 do not decrease the number of rounds (Table 3.2), thus 46 was chosen as the batch size for pathway 





Batch size Points before max Batches before max Includes error? 
1 12 12 NO 
1 18 18 YES 
8 40 5 YES 
46 92 2 YES 
92 184 2 YES 
 
Table 3.2. Batch size optimization. The batch size was changed from 1 to 92 samples sample per batch and 




3.3.4. T7 promoter library construction 
 To perform the expression tuning for pathway optimization, regulatory elements must be developed 
to control the expression level of the enzymes in the pathway of interest. Relying on previously published 
work, we mutated a region in the  T7 promoter that has been attributed to its strength (35, 36) to find 
promoters with a wide range of expression levels.  We developed 12 promoters with distinct strengths. We 
then designed and tested two Ribosome Binding Sites (RBS) using the RBS library calculator (2, 37) with 
vastly different strengths. The resulting T7p-RBS combinations resulted in 24 distinct expression levels 






Figure 3.4. Evaluation of 192 T7 promoter mutants and two RBSs resulted in 24 T7p-RBS combinations 
with ~1000X dynamic range 
 
3.3.5. Automated experimental design and results 
 The pathway optimization workflow was performed using the Illinois Biological Foundry for 
Advanced Biomanufacturing (iBioFAB) developed in our laboratory (28) and has been used for high-
throughput TALEN synthesis (53) and automated yeast genome engineering (54). By harnessing the power 
of iBioFAB as well as Bayesian optimization, all aspects of the design, build, test and learn cycles were 
automated. In each round, the Bayesian optimization algorithm chose the 46 points to be evaluated and 
gave it to the iBioFAB scheduling software. The software then pipetted the correct parts to be assembled 
from the parts library and assembled the plasmids using Golden Gate assembly. The lycopene production 
for the points was then measured and the results were given back to the algorithm to calculate the next 
points to be evaluated. The Bayesian optimization algorithm starts by uniformly exploring the entire 
landscape (Figure 3.5a) and gets less uniform in later rounds (Figures 3.5b and 3.5c) where more 
information is available from the landscape. In round 2, there is still some exploration while the points in 
the third round are a lot closer to each other and have almost exclusively converged to one specific region 





Figure 3.5. Change in sampling behaviour of baysesian optimization. In the first round (a), all points were 
chosen to uniformally explore the landscape since it is completely unexplored and unknown. In the second 
round (b), some information is acquired and the points picked by the algorithm are clearly skewed from the 
unifrom distribution. However, since there is still some uncertainty, it is still exploring the landscape. 
Finally, in the third round (c), a clear pattern is observed where the algorithm has determined the points in 
a particular area are more likely to be closer to the global optima and is actively exploring that area but still 
doing some minimal exploration. 
 
 The lycopene production in different rounds are compared to each other in Figure 3.6, and it is 
observed that the later rounds of pathway optimization have higher average lycopene production and higher 
maximum production which shows the effectiveness of the active learning algorithm in finding better 
mutants in each subsequent round. To better compare the active learning algorithm with traditional random 
library screening, a random library was constructed and 46 (the same number as points in each round) and 
136 (the same number as the points in all three rounds) random colonies were picked and lycopene 
production was measured (shown in Figure 3.6). The average and maximum found by random screening 
are 1.43 and 1.93 times less than results from the third round of pathway optimization. Even by evaluating 
138 random points, the maximum found was 1.77 times smaller than the maximum from the third round.  
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Figure 3.6. Comparing the distribution of lycopene production in different rounds of pathway optimization 
and random screening. The average and maximum point have increased after each round of pathway 
optimization. Moreover, although the average and maximum of random points are a little more than the 
uniform distribution in round 1, they are significantly lower than the points picked by the algorithm in the 
subsequent rounds 
 
 The best lycopene producers of each round were also isolated and characterized in test tubes and 
lycopene production was quantified using traditional acetone extraction. The pathway with the medium 
level expression for all genes was also chosen as the control and the lycopene production for all these four 
samples were analyzed in one batch with four biological replicates and compared to the control (Figure 
3.7). It was observed that the best combination in each round had increased significantly and the best overall 





Figure 3.7. Comparison of the best lycopene producers in each round of pathway optimization. 
 
3.4. Discussion 
Given the complex nature of chemical biosynthesis and our limited knowledge of the myriad of 
interactions between different elements in cells, rational design and optimization can be unattainable for 
some applications. Knowing that the enzyme concentration directly affects the flux of the reactions they 
catalyze and acknowledging our limited knowledge about other aspects, we can use black-box optimization 
methods to find the best enzyme concentration to maximize the flux and production. One of the most 
common ways of finding the maximum of a black box function is evaluating the output given different 
inputs and learning about the function as more inputs are evaluated. Our estimation of the black box function 
gets closer to the real function as more points are evaluated. However, in experimental biology each 
evaluation is costly, and it is crucial to reduce the number of evaluations, especially where the expression-
production landscape is large and cannot be exhaustively searched.  
In this work, we presented a fully-automated algorithm-driven optimization platform where the 
machine performs all the steps in the optimization process. The iBioFAB was integrated with the machine 
learning algorithm where after the initial design and setup, the algorithm decides what experiments to 
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perform, the robot performs the experiments and returns the data to the algorithm and it will then decide 
the next point to be evaluated. Machine learning enables exploration of large dimensional optimization 
problems whereas our intuition is mostly limited to three dimensions. Active learning enables faster and 
more targeted optimization by only focusing on areas of high interest and uncertainty, deals with the 
experimental data by incorporating the uncertainty of experiments, and actively tries to reduce the number 
of experiments thus reducing the cost. This system, Roboscientist, is less biased, can process high-
dimensional data, makes fewer mistakes and can find the optimum with very few evaluations. 
To demonstrate one of Roboscientist’s applications and as a proof of concept, we set to optimize 
the flux of lycopene biosynthesis pathway. We were able to tune the gene-expression of this 3-gene pathway 
to find the optimum expression for the most lycopene production by evaluating less than 1% of all 13,824 
possibilities. We also compared this optimization scheme with another previously reported regression 
model as well as random sampling and found it to be superior to both in performance. The best mutant 
found using the RoboScientist was 1.77 times better than random sampling and simulation showed that the 
number of evaluations was at least 8 times less than the regression-based optimization scheme. 
Although the algorithm is especially powerful when used in combination with a fully-automated 
system like iBioFAB, it can be easily adopted for use in semi-automated or manual settings where reducing 
the number of evaluations is even more important due to the higher experimental cost. Other models and 
optimization algorithms are available, however we chose to use Gaussian process given its successful 
implementation in biological systems (15, 16). An area of possible improvement is the initial guess of the 
landscape for optimization. Here, we did not make any initial assumptions about the landscape, however, 
using the trained model for one system as the starting point for a similar system has been shown to be a 
powerful method and this educated guess results in reducing the number of evaluations to find the maximum 
(49). 
The prospect of autonomous algorithm-driven robotic systems to engineer biology has many 
promises and challenges. On one hand, human supervision is crucial to maintain ethical issues surrounding 
the autonomous engineering of life and keeping a check on the extent of what the machine does and 
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achieves. On the other hand, an autonomous algorithm-driven robotic system which is connected to the web 
of knowledge can both learn from published information and publish the results of its experiments in real-
time. Other than the obvious advantages of reducing the cost and accuracy of research, the connected web 
of RoboScientists can significantly reduce the time from performing experiments to publishing the data. 
These class of Roboscientists will greatly benefit from standardization of data and following standards set 
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Chapter 4: Design and Characterization of Golden Gate Overhangs 
 
4.1. Introduction 
For biosynthesis of any molecule, the DNA components such as genes and regulatory elements 
must be assembled together and transformed in the host cell for production. Therefore, in many cases, DNA 
assembly is one of the first and major steps in the build part of the Design, Build, Test and Learn (DBTL) 
cycle, therefore a robust assembly method is crucial for a fully-automated and flexible execution of this 
cycle. Using a low-efficiency and low-fidelity assembly method significantly increases the complexity of 
the process by making the expensive and inefficient step of quality control inevitable. 
Due to the importance of DNA assembly, there have been many methods developed from the dawn 
of recombinant DNA technology. DNA assembler (1), Ligase Cycling Reaction (LCR) (2), Gibson 
assembly (3)  and Golden Gate assembly (4) are just a few of the most widely used and successful examples 
of this technology(5–7). Golden Gate assembly has been given special attention due to its flexibility and 
compatibility with automated systems which makes this method ideal for combinatorial DNA assembly. 
The Golden Gate method relies on digestion with Type IIS endonucleases whose recognition site 
is adjacent to the cut site (Figure 4.1A). The advantage of this mode of cleavage is that the sequence of the 
recognition site is independent of that of the cut site, hence the resulting four base overhangs is 
customizable. This flexibility in choosing specific overhang sequences enables the user to design different 
overhangs for each junction. In the subsequent ligation step, the sticky ends are exposed, and 
complementary overhangs are ligated. Consequently, the assembly of the desired parts in the desired order 
can be achieved (Figure 4.1). Because of its flexibility and modularity, this method was quickly adopted 
as the gold standard for DNA assembly. Researchers have used it for a myriad of applications from large-
scale TALEN synthesis (8, 9) to natural product discovery (10) . Because of the widespread use of this 
method, many variations and improvements have been developed. However, this method has some 
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limitations shown in Figure 4.1B, the 4 bp overhangs remain in the final assembled product, causing a 
“scar” in the Golden Gate product. Moreover, all the parts in the Golden Gate reaction must be free from 
the BsaI recognition site to avoid cleavage in the middle of those sequences. However, due to the relatively 
short length of the BsaI (6 bp) recognition site, it is relatively common in the DNA and appears every ~2 
kb on average.   
 
Figure 4.1. Golden Gate assembly scheme. A) BsaI cleaves the DNA outside of the recognition site, 
resulting in a flexible and customizable 4 bp overhang. B) The BsaI-OH1-Gene-OH2-BsaI is constructed 
using PCR amplification and customized sticky ends are generated using BsaI digestion and assembled by 
ligation, connecting all the parts and leaving a 4 bp scar between the junctions. 
 
 As shown in Figure 4.1, a customizable 4 bp overhang is used in Golden Gate assembly and it has 
been shown that the sequence of this overhang plays a critical role in the efficiency and fidelity of the 
assembly. It was found that the probability of mis-assembly is increased if the junctions are similar to each 
other and the efficiency decreases as the junctions become more A/T rich (8) due to the lower binding 
affinity of A to T compared to that of C to G. Although the effect of overhangs on assemblies has been 
 64 
shown, there is little study on the efficiency of Golden Gate overhangs. Liang and co-workers have come 
up with a few guidelines for designing 17 overhangs (8) with high efficiency and fidelity. These optimized 
overhangs have been used in multiple studies and Chao and co-workers (9) found them to be very efficient 
in assembling large numbers of DNA parts. The guidelines for these assemblies are as follows: 
1. GC content of at least 50% 
2. Non- palindromic 
3. Not the same as the reverse-complement of any other junction 
 These guidelines are a great starting point for assembly design and have been working with decent 
efficiency, however this is a small set of overhangs and is by no means a comprehensive or the most efficient 
list. Given the extent to which Golden Gate assembly is performed and the effect of Golden Gate overhangs 
on the efficiency, a comprehensive study of overhangs is needed. The optimized overhangs can also be used 
for efficient scar-less assembly and BsaI removal. Performing the scar-less assembly introduces a constrain 
on the Golden Gate overhangs that can be used and there may be many cases where the current optimized 
overhangs may not be found in the areas next to the junction of two DNA parts. This problem can be 
resolved by having larger sets of overhangs that are compatible with each other. The overhangs in each set 
are highly efficient and compatible with each other but not necessarily with overhangs in other sets. 
 Here we devised an assembly and sequencing scheme where the efficiency and fidelity of all 4-
base pair Golden Gate overhangs are experimentally evaluated and tested. The sequencing results generated 
a matrix showing the likelihood of each pair of overhangs ligating together. The likelihood of each overhang 
ligating to itself can be interpreted as the efficiency of that overhang and the likelihood of each overhang 
ligating to others can be interpreted as the compatibility of those overhangs. This information was later 
used to determine 200 sets of overhangs with different sizes that have good efficiencies and compatibility 
with all the overhangs in the same set. These sets were later used for performing single-pot scar-less Golden 
Gate assembly and BsaI removal.   
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4.2. Materials and methods 
4.2.1. Strains, media and cultivation conditions 
 
 DH5α E. coli (New England Biolabs, Ipswich, MA) cells were used for making chemically 
competent cells using a Mix & Go E. coli Transformation Kit (Zymo Research, Irvine, CA) for plasmid 
amplification. E. coli cells were grown in Luria Broth (LB) medium (Fisher Scientific, Pittsburgh, PA) 
supplemented with 25 μg/mL kanamycin (Kan) or 50μg/mL of spectinomycin (Spec) to maintain the 
plasmid. Antibiotics were purchased from Gold Biotechnology (St. Louis, MO). DH5α E. coli cells, starter 
cell cultures, were grown at 37°C. 
4.2.2. DNA manipulation and library construction 
 
All 192 primers were designed using Python programming language and ordered through IDT DNA 
(Coralville, IA). The primers were then normalized to 100 pm/μL and 10 pm/μL using an EPMotion robotic 
system Eppendorf (Hamburg, Germany). 
 The primer library was used to amplify the pSPE backbone containing UPB1-EcoRV-UPB2 
digested with EcoRV and the PCR product was gel purified. 500 ng of the purified library was used in a 20 
μl Golden Gate reaction consists of 10 units of BsaI restriction enzyme, 10 units of T4 DNA ligase, 2 μl of 
CutSmart buffer and 0.75 μl of ATP (25mM). After Golden Gate reaction, 5 μl of plasmid safe nuclease 
(Illumina, San Diego, CA) and BsaI master mix (2.5 units BsaI, 2.5 units of plasmid safe nuclease, 0.5 μL 
CutSmart buffer and 1 μL ATP (25 mM)) was added to the reaction to linearize undigested backbone and 
remove all the linear parts from the mixture. The Golden Gate and plasmid safe master mix protocols have 
been adopted from our previous work (8) with some modifications but the thermocycling protocol has 
remained unchanged.  
A QIAGEN Plasmid Mini Kit (QIAGEN, Valencia, CA) was used to isolate plasmids from E. coli 
cells and Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA) was used for gel purification. 
All restriction enzymes, Q5 polymerase, Gibson Assembly master mix components and the E. coli shuttle 
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vectors were purchased from New England Biolabs (Ipswich, MA) and all chemicals were purchased from 
Sigma-Aldrich (St. Louis, MO) unless otherwise specified. 
4.2.3. Next generation sequencing library construction and analysis 
 
To attach NGS adaptors, a first step PCR was performed using 2×KAPA HiFi HotStart Ready Mix 
(Kapa Biosystems, Wilmington, MA) 10 ng extracted plasmid as template. The cycling condition was 95 
°C for 3 min, (95 °C for 30 s, 46 °C for 30 s, 72 °C for 30 s) × 18 cycles, 72 °C for 5 min, and held at 4 °C. 
The PCR product was gel purified and 10 ng PCR product from the first step was used in a second step 
PCR to attach Nextera indexes using the Nextera Index kit (Illumina, San Diego, CA). The cycling 
condition was 95 °C for 3 min, (95 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s) × 8 cycles, 72 °C for 5 min, 
and held at 4 °C. The second step PCR products were gel purified and quantitated with NanoDrop 
(ThermoFisher Scientific, Waltham, MA) and 40 ng of the library was then sequenced on one lane for 161 
cycles from one end of the fragments on a HiSeq 2500 using a HiSeq SBS sequencing kit version 4 
(Illumina, San Diego, CA).  
Fastq files were generated and de-multiplexed with the bcl2fastq v2.17.1.14 conversion software 
(Illumina, San Diego, CA) and uploaded to the Galaxy website (https://usegalaxy.org). The fastq reads were 
trimmed to only include barcode1-overhang-barcode2 using the “fastqtrimmer” command. However, since 
the sequence of the overhang was not obvious in the mismatched assemblies, the overhang sequence had 
to be removed leaving only barcode1-barcode2 to be analyzed. To do this, ”split” command was used to 
divide the sequence in two from the middle and “fastqtrimmer” was used to remove the ends of each 
sequence and “join” was used to reconnect these sequences resulting in barcode1-barcode2 sequence. A 
bowtie index was prepared using Python programming language from each two-barcode combination 
(96*96=9216). Extracted barcode sequences were mapped to the bowtie index using the Map with Bowtie 
for Illumina (version 1.1.2) command in Galaxy with commonly used settings. Unmapped reads were 
removed and the reads were mapped to each unique barcode sequence and were counted.  
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4.3. Results  
4.3.1. ΔG calculations 
 Given the four-base length of Golden Gate overhangs, the total number of all possible overhangs 
is 256. After removing the sequences with reverse complements in the list, 120 overhangs remain. The ΔG 
of binding was calculated for all 120 overhangs using the nearest neighbors method (11) implemented in 
the BioPython library. We then used a modified nearest neighbor method (12) for calculating the mismatch 
ΔG for all of the overhang pairs and generated a matrix showing the efficiency and fidelity of each 
overhang. The affinity of each overhang to itself, i.e. low ΔG represents high efficiency of the overhang 
and low affinity of the overhang to others, i.e. high ΔG represents fidelity of the overhang.  This matrix can 
be interpreted to estimate the efficiency of each overhang and its fidelity and likelihood of mismatch with 
other overhangs. As shown by the heat map for the ΔG in Figure 4.2., the ΔG on the diagonal elements of 
matrix is much lower than the other elements. However, there are many pairs that have negative ΔG values 
that could result in a mismatch. The ΔG calculation is a great starting point for finding compatible 
overhangs, however, this is only a ΔG calculation and may not necessarily be a good representation of real 
efficiency and fidelity, we sought to experimentally find the fidelity and efficiency of all overhangs and 




Figure 4.2. ΔG of annealing heat map of all 120 overhangs sorted from low to high. The overhangs that 
have low ΔG of annealing with themselves are the most efficient and the ones with high ΔG of annealing 
with others should be used in the same reaction. If two overhangs have low ΔG of binding with each 
other, they could misanneal with each other in Golden Gate reaction.  
 
4.3.2. Large-scale design and preparation of primers 
 To experimentally evaluate the efficiency and fidelity of Golden Gate overhangs, 96 top overhangs 
with the lowest binding ΔG with themselves and consequently, the highest binding affinity were chosen for 
evaluation and constructing a similar matrix as Figure 4.2 that is experimentally verified. To perform the 
experiments, we sought to create a library of overhangs with a BsaI site, perform Golden Gate assembly 
and determine which of the overhangs assembles to the incorrect overhang and which one assembles 
correctly. The number of misassemblies and correct assemblies represent the fidelity and efficiency of each 
overhang pair. To this end, a library of primers consisting of a universal primer binding (UPB) site, an 8 bp 
barcode, overhang, BsaI recognition site, and 2 bp protection sequences were designed as shown in Figure 
4.3. For designing the UPB, 100,000 random 20 bp sequences were generated and two of them that have 
the least homology with each other and have a GC content of between 40% and 60% were chosen. The 
barcodes were also chosen from the previously reported list of 240,000 orthogonal barcodes (13). Since 
only 96 barcodes had to be chosen, we could afford to be more selective and choose the barcodes that 
resulted in the most optimized primers. We iterated through the barcodes and chose the ones that when 
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combined with the rest of the primer components (BsaI, UPB, overhangs, and protection sequence), have 
low homology with the plasmid, as well as the other primers, melting temperatures between 68°C and 70°C, 
contain no poly A, T, C and G, contain no extra BsaI site and the GC content is between 35% and 65%.  
 
  
Figure 4.3. The overall scheme of library design. A library of 96 forward and 96 reverse promoters 
containing Universal Primer Binding regions, barcodes, overhangs and BsaI recognition site were used to 
amplify pSPE backbone.  
 
4.3.3. PCR amplification and sequencing results 
 PCR reactions were performed with equimolar amounts of all primers in the library as the primer 
mix and the digested pSPE backbone as the template. The library of linear PCR products with different 
barcodes and overhangs were then used in Golden Gate reaction and plasmid safe digestions (Figure 4.4A). 
The region between both UPBs can be sequenced and the barcodes identified. By seeing which barcodes 
are connected to each other, we can see which overhangs were assembled and estimate the efficiency and 
fidelity of each Golden Gate overhang. The Golden Gate product library was transformed into Stellar 
competent cells and purified after 3 hours of growth. The region of the plasmid containing barcodes and 
overhangs were then amplified using a Nextera DNA Library Preparation kit and ran on a gel to assess the 




A B   
Figure 4.4. A) The PCR product was assembled using Golden Gate method and the assembled product 
contains barcode-overhang-barcode sequence which can be read by NGS to identify the overhangs in the 
assembly. B) The barcode-overhang-barcode sequence was amplified using and purified to be sent for NGS 
analysis. 
 
The library was sent for next generation sequencing and the sequencing results were analyzed. A 
subset of the sequencing results is shown in Table 4.1. Each cell of the matrix shows the number of times 
each pair of overhangs are observed together.  
 
ccct (27) gctc (31) cggt (14) gtgc (19) ctgt (62) tgct (26) gact (68) tccg (17) gttg (72) ccat (61) 
ccct (27) 10437 2 2 2 131 2 42 69 0 2930 
gctc (31) 
 
10102 3 9 12 1 1 1 2 4 
cggt (14) 
  
6637 1 6705 1 0 1 2 76 
gtgc (19) 
   
5601 14 1 0 0 86 31 
ctgt (62) 
    
10748 2 0 3 1 11 
tgct (26) 
     
4282 9 1 1 1 
gact (68) 
      
7865 0 13 1 
tccg (17) 
       
4990 4 0 
gttg (72) 
        
7933 39 
ccat (61) 
         
7508 
 
Table 4.1. The sequencing results for the optimized overhangs reported in Liang and coworkers (8). The 
diagonal elements show the affinity of each overhang to itself and the non-diagonal elements show the 




 The set of overhangs in Table 4.1 is a subset of the optimized overhangs reported by Liang and co-
workers (8). Each cell in the matrix shows the number of times each pair of overhangs have been seen with 
each other, therefore representative of their binding affinity. The diagonal values show the affinity of each 
overhang to itself (the higher the better) and the non-diagonal values represent the affinity of each overhang 
to a mismatch (the lower the better).  As expected, the diagonal values of this matrix are orders of magnitude 
higher than most non-diagonal values since each overhang binds better with itself than a mismatch. 
However, in this set of previously optimized overhangs, two pairs seem to have high mismatch rates 
(ctgt/cggt and ccct/ccat). By looking closely at the sequence of these two overhangs we can see that both 
pairs are only different by one base, this could explain the mismatch and was not considered to be important 
previously. We also see that there is no clear pattern between the affinity of an overhang with itself and 
ΔG, e.g. cggt was ranked 14th in the ΔG list but has less affinity with itself than ctgt which is ranked 62nd 
in the list. This demonstrates the need for experimental verification and the unreliable correlation between 
ΔG and affinities for the Golden Gate reaction. 
 
4.3.4. Finding optimized overhang sets  
 The above-mentioned study by Liang and co-workers suggested guidelines to find optimized 
overhangs, however, only one set of optimized overhangs was introduced. Since there may be many sets 
that include efficient overhangs, but those overhangs may cause mismatches when used with other sets, we 
chose to find different sets of overhangs with different sizes. Each set is very efficient by itself and if all of 
the overhangs in the assembly are chosen from one set, the fidelity is also relatively high. To find each set, 
many sets were tested in silico and the best was chosen from all the possible candidates. These sets can be 
used for efficient Golden Gate assembly and since there are more options to choose from, the smaller sets 
are more efficient than the larger ones and the smallest sets should be used if possible. We used Python 
programming language to design 5 sets for each one of the sizes 10 to 50, resulting in 200 different sets of 
optimized overhangs. The program first generates 10 million different sets of a given size and finds the 
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ones with the highest efficiency and fidelity. It then finds 5 of the most distinct sets with the least overlap 
among the high efficiency, high fidelity sets. 
 
4.3.5. Proof of concept for scar-less Golden Gate assembly and BsaI removal 
 Leveraging these sets of optimized overhangs, we can develop a scar-less assembly method where 
the BsaI site removed, if necessary, and DNA assembly can be performed in one step without leaving any 
scars between the junctions. To perform seamless assembly, the region around the junction of the pieces to 
be assembled was searched and one of the optimized overhangs was chosen (Figure 4.5A). The overhang 
and the remaining bases on each part were then added to the other part in the assembly along with BsaI 
recognition site. The two parts then went through Golden Gate assembly and after multiple digestion and 
ligations, were assembled without introducing any scars. This can be extended to a multi-piece Golden Gate 
assembly. The sets of optimized overhangs are especially important for this purpose given the limited region 
where an optimized overhang must be found. By finding many distinct sets of overhangs with sizes from 
10 to 50, the likelihood of finding a set in each of the junctions is significantly increased. We can use the 
same principle for silent mutations of BsaI from each of the genes in the construct by treating the BsaI site 
as a junction and design the correct primers to re-assemble the junction but silently mutating BsaI using the 





Figure 4.5. Scar-less simultaneous Golden Gate assembly and BsaI removal. A) The region in the vicinity 
of the junction is searched for optimized overhang and the overhang (shown in different colors) as well as 
BsaI site are added to the end of each part using PCR reaction. The parts can later be assembled by Golden 
Gate reaction. B) The same principles can be extended to a multi-piece assembly system as well as BsaI 
removal by just repeating the same process and treating BsaI site as a junction that has to be silently mutated 
with modified primers. 
 
 As a proof of concept, a three-piece DNA assembly was performed by amplifying the ampicillin 
resistance gene that contains the BsaI site and cloning it into the pET26 (b) backbone. The ampicillin 
resistance gene was divided into two parts by PCR, adding the overhangs as well as BsaI sites to the ends 
of each part. The pET26 (b) backbone was also linearized with PCR amplification by addition of matching 
overhangs and BsaI sites. The three pieces were then used for Golden Gate assembly and 9 out of 10 
colonies evaluated grew both on ampicillin and kanamycin, demonstrating correct assembly. 
 
4.4. Discussion and future work 
 DNA assembly is one of the cornerstones of synthetic biology. Golden Gate assembly is one of the 
most efficient and versatile DNA assembly methods to date and is used in the pathway optimization project 
described in Chapter 3. The importance of overhangs in efficiency and fidelity of assembly has been 
demonstrated previously and some rough guidelines have been introduced for designing overhangs used in 
the Golden Gate assembly. High-efficiency and fidelity are especially important since as shown in Chapter 
3, if the assembly efficiency is poor or low then a quality control step must be added which will over-
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complicate the workflow. It can also be used for single-pot scar-less Golden Gate assembly, eliminating 
two of the major problems with Golden Gate assembly. 
 We designed a method in which next generation sequencing was used to evaluate the overhangs in 
the Golden Gate assembly method to determine their efficiency and fidelity. These sets of overhangs can 
be used for regular digestion/ligation DNA assemblies as well to find the compatibility of different 
restriction enzymes. These overhangs can also determine the likelihood of the sticky ends they generate are 
efficient or have low mismatch with other overhangs in the mixture. These sets of optimized overhangs can 
also be used for single pot scar-less Golden Gate assembly and BsaI site removal. The data presented here 
can also be used for designing overhangs for assembly with Artificial Restriction Enzymes (14) (AREs).  
In this case any loci can be targeted, and custom overhangs can be generated to estimate the efficiency and 
fidelity of 4bp overhangs. The library creation and sequencing method can also be used to characterize 
longer overhangs, although the cost and complexity of primer design for longer overhangs increases 
exponentially due to the increase in the total number of possible overhangs. 
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Chapter 5: Automation of Design, iBioCAD and Guide RNA Design 
 
5.1. Introduction 
A crucial step in the Design, Build, Test and Learn (DBTL) cycle which has been given little 
attention to is the design step. Historically, the number of experiments in each round of DBTL has been 
relatively small and most of the time has been spent in the build and test parts of the cycle. Therefore, 
scientists have spent most of their time either performing literature surveys or doing experiments and 
relatively little time has been spent on the design, DNA design is an example. However, with the advent of 
automation and high-throughput techniques for experimentation from advanced liquid handlers to high-
throughput sequencing machines as well as inexpensive DNA synthesis, automation of design has become 
more and more important. The need is especially felt for genome scale library and combinatorial pathway 
engineering designs. Here, we have developed software tools for both applications that have been used to 
design millions of DNA molecules and more than a hundred thousand of those molecules have been 
synthesized and used in five different projects. 
5.1.1. Genome scale gRNA design tool 
 
The clustered regularly interspaced short palindromic repeats (CRISPR) system has been recently 
developed for multiplex genome engineering in nearly all kingdoms of life (1–4). In this modular and highly 
efficient system, a guide RNA (gRNA) recruits a CRISPR nuclease to a specific region of the genome, 
resulting in a double strand break at that specific site. By mutating the nuclease domains, the CRISPR 
protein can still bind to the target region, but without introducing a double strand break. In this case, 
transcriptional activation or interference can be achieved by fusing an activation or repression domain to 
the nuclease-deficient CRISPR protein (5–8). In other words, the CRISPR system has been demonstrated 
to have the capability of transcriptional activation (CRISPRa), transcriptional interference (CRISPRi), and 
gene deletion (CRISPRd). Particularly in Saccharomyces cerevisiae, one of the prominent microbial cell 
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factories for industrial applications, the CRISPR system has been widely used for multiplex genome editing, 
such as gene deletion and genome integration of heterologous genes and pathways (9–14) . 
Given the vastly different requirements for guide RNAs for each application and the complexity of 
those requirements, computational tools are crucial for designing gRNAs to target the best regions to 
perform the function of interest. There are many areas where computational tools are especially important 
such as efficiency and specificity of gRNAs as well as where large-scale design is required. Specificity of 
binding to a particular locus and the efficiency of binding are difficult to determine manually without good 
computer programs and algorithms. Moreover, selection of the loci to be targeted which can perform the 
function of interest while having good specificity and efficiency is very challenging. In some applications, 
many guides need to be designed to target many loci in the genome. These guides must be ranked for the 
best ones to be chosen, which is close to impossible to be done manually. There are many applications 
currently available, but they have vastly different functionalities ranging from versatile PAM sequences to 
sophisticated algorithms for calculating specificity and efficiency. 
Specificity 
Specificity of gRNAs is especially important because off-target effects can considerably damage 
the genome and cause unknown changes. If an unintended locus is accidentally cleaved, it can either kill 
the cell or cause unknown genomic reconfiguration, causing unexpected outcomes. This can happen in cells 
where the locus of interest has already been cleaved and mutated and there are still many gRNAs and Cas9 
proteins present in the cell searching for the next locus to cleave. Specificity of gRNAs is mostly determined 
by the similarity of the designed gRNA to other locations in the genome, which is important in larger 
genomes but still crucial in organisms with smaller genomes like S. cerevisiae. Most of the algorithms for 
finding the specificity of any given gRNA finds the number of locations in the genome that a sequence with 
high homology to the guide exists. For example, CRISPRdirect (15) returns the number of 8, 12 and 18 -
mers in the genome that match each calculated guide. Other applications like CHOPCHOP (16) enable the 
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user to choose between different criteria such as number of mismatches in the protospacer (17)  or the 
protospacer seed region (18). 
Affinity 
The binding affinity of gRNAs is of great importance when choosing a gRNA for targeting since 
all the desired functions (transcriptional activation, interference and gene deletion) depend on the efficient 
binding of the Cas9 protein to the target. There are many publications that have experimentally determined 
the motifs that increase the binding affinity of different Cas9 proteins. However, since most of the CRISPR 
targeting is done using the Cas9 protein isolated from Streptococcus pyogenes (spCas9), the most extensive 
set of rules are available for this Cas9. For example, CHOPCHOP software (16, 19) covers a wide array of 
scoring systems for the estimation of affinity. These scoring criteria are obtained from three signature 
articles for spCas9 with the  NGG PAM sequence that have motifs next to the PAM that affect the binding 
(20, 21) and other sequence specific scoring systems (22). There are also more targeted scoring systems for 
more specific applications (23) where the scores have only been obtained and validated in certain genomes 
such as the Mus musculus genome (mm10) and the Homo sapiens  genome (hg19) and some generic 
methods like G20 which only evaluates if the last base of the guide is a G. 
Large-scale gRNA design 
Another area where computer aided gRNA design is especially important is large-scale or genome-
wide library construction. These libraries are often as large as hundreds of thousands of guides and their 
manual design is close to impossible. Although there are many software packages that can design single 
guide sequences, there are a relatively few free software packages available for large-scale design because 
it is computationally intensive, and a significant amount of computational power is required to sustain the 
ever-growing demand for gRNA design. For example, one of the first and most widely used CRISPR design 
websites http://crispr.mit.edu/ obtains the chromosomal region of interest from the user and sends the results 
via email with a few minutes delay due to the high demand on their servers. Fortunately, the authors of 
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CRISPRdirect (24) have offered a generously fast solution to the CRISPR community where an Application 
Program Interface (API) can be easily written to communicate with their servers and get the gRNA results 
within seconds of submission. This code snippet can be included in any program and allow for flexible and 
large-scale design of gRNAs. This is the most convenient way of designing large scale guide RNAs for 
spCas9 with a PAM sequence of NGG.  However, due to the inflexibility of CRISPRdirect, it cannot be 
used for all applications, especially if the PAM sequence is different than that of spCas9. The authors of 
CHOPCHOP software however, have made its source code public 
(https://bitbucket.org/valenlab/chopchop)  and it can be used to run large-scale design of gRNAs for a 
variety of different Cas9 and Cpf1 nucleases as well as target genomes. This flexibility allows the users to 
even use custom genomes as an input to the software and design specific guides to target different loci in 
that genome. 
5.1.2. Plasmid assembly tools 
 
There are a variety of plasmid design software with different strengths and weaknesses. Given the 
variety and differences between the DNA assembly methods, it can be tricky to choose the right one. Some 
of the assembly methods perform the best for assemblies with longer DNA pieces and some others with 
more pieces. Sometimes it is easier and even more cost-effective to synthesize some of the parts than 
obtaining them from other sources. The j5 DNA design software suggests when DNA synthesis is cost-
effective so that the users can synthesize the DNA instead of other methods of procurement(25). The 
success rate of the assembly in some cases also depends on the sequence of the parts being assembled. For 
instance, if the parts have high sequence homology with each other, DNA assembler may not be the ideal 
strategy because mis-assemblies are likely to happen. 
These sequence dependencies are difficult to detect manually, and computational tools are required 
to suggest the best assembly strategy. If not considered carefully, many problems may arise because of 
these intricacies. One of the most widely used DNA assembly automation packages is j5, which designs 
combinatorial libraries and hierarchical assemblies with its extensive design rules (25). It also takes 
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advantage of the ever-decreasing cost of DNA synthesis and suggests synthesis when it is cost effective to 
do so. j5 has an extensive cost optimization option which not only helps with the assembly protocol but 
also optimizes the cost, making it a useful tool for construction of a large number of pathways (26). 
Another software package, Raven has an interactive learning function and can interact with the user 
(27). This package designs the assembly strategy but gets feedback from the user and if one of the steps of 
the assembly does not work for any reason, it changes the strategy to avoid that specific step. This package 
was reported to outperform the non-optimized assemblies with the p value of <0.0001. 
Here we have developed two pieces of software for automated design of large scale libraries both 
for plasmid assembly and genome editing and expression tuning by building on the existing tools. The 
large-scale gRNA design software helps researchers choose any sets of genes in the genome and either 
increases or decreases the expression of the target genes or disrupts or mutates parts of the target genes. 
They can also edit each gene in the genome with base pair resolution and mutate any amino acid to any 
other desired amino acid. We also developed a plasmid assembly website that enables the user to design 
combinatorial plasmid libraries where multiple DNA sequences are entered for each location on the plasmid 
and all different possibilities are designed and the promoters for the design are also generated and exported 
for synthesis. 
5.2. Results and discussion 
5.2.1. Large scale gRNA design 
 
The gRNA design tools described here have been used in a variety of different applications from 
the disruption of all open reading frames in the yeast genome (28) to activation and interference of all the 
genes in the yeast genome for better industrial yeast strains (29). The gRNA design tools used in this study, 
CRISPRdirect (15) and CHOPCHOP (19, 30) have been modified for each of the applications to address 
the specific need of that application however, the underlying scoring system is mostly unchanged.  
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CHAnGE library design for single nucleotide precision editing of the yeast genome 
In this project, we designed a gRNA library to use CRISPR/Cas9 and a homology-directed repair 
assisted genome-scale engineering (10) (CHAnGE) method that enables a single researcher to generate a 
genome-wide library of yeast gene disruption mutants each with a specific 8 nucleotides removed within a 
month. The CHAnGE method was validated by the genome-wide identification of single gene disruption 
mutant strains that showed 5~7 fold improved tolerance to different growth inhibitors including acetic acid 
and furfural. We then iterated CHAnGE for the directed evolution of yeast strains, achieving an additional 
3~8 fold improvement. We further showed that CHAnGE enabled one-step, multiplexable, near 100% 
efficiency in vivo site directed mutagenesis for generating natively expressed amino acid level protein 
mutants for CAN1, UBC4, and SIZ1, thereby achieving single-nucleotide resolution genome engineering. 
To demonstrate the precise targeting of the gRNA designs, we targeted and sought to change all amino 
acids in the BUL gene of the S. cerevisiae genome to alanine in a library and by doing screening, we were 
able to identify beneficial mutations to demonstrate the power of this method to successfully change all the 
amino acids in one single gene. We then sought to change all the amino acids of a particular region to every 
other possible amino acid for both the UBC4 and SIZ1 genes. In the generation of both the gene disruption 
and editing, more than 700,000 guide RNA molecules were designed and more than 26,000 of them were 
synthesized and pooled to perform the screening.  
The previously described criteria (31–33) maximizing the efficacy and specificity of CRISPR guide 
sequences (Table 5.1) were adopted for scoring all possible guide sequences targeting each annotated Open 
Reading Frame (ORF) in the S. cerevisiae genome. Artificial weights were assigned to each efficacy 
criterion so that higher scores will be given to guide sequences with 35% to 75% GC content, with high 
purine content in the last four nucleotides, and targeting earlier regions of the ORF. To ensure targeting 
specificity, the score of a guide sequence decreases exponentially as the number of its off-target sites 
increases. An off-target site is defined as a site containing a matching 12 bp seed sequence (31) followed 
by a protospacer adjacent motif (PAM) for Cas9 recognition. For each ORF, we ranked all the targeting 
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guide sequences according to their scores in a descending order. For most of the ORFs, we selected the four 
top-ranked guide sequences to include in the CHAnGE library. For some of the ORFs, less than four guide 
sequences were selected due to the short ORF length or the repetitive nature of the sequence. We also 
included 100 randomly generated guide sequences that do not target any part of the S. cerevisiae genome, 
as non-editing controls in the library. In summary, we managed to design 24,765 unique guide sequences 
targeting 6,459 ORFs (~97.8% of all ORFs annotated in SGD as of Apr 16th, 2017) plus 100 non-targeting 
guide sequences (Table 5.2). For each ORF-targeting guide sequence, a corresponding 100 bp Homology 
Recombination (HR) template with 50 bp homology arms and a centered 8 bp precise deletion was placed 
upstream of the guide sequence. The 8 bp deletion simultaneously removes the PAM sequence and causes 
a frame shift mutation for gene disruption (Figure 5.1). For each non-targeting guide sequence, a 100 bp 
HR template with a randomly generated sequence was placed upstream of the guide sequence. Adapters 
containing priming and BsaI sites for cloning of the CHAnGE library were added to the 5’ and 3’ ends of 
the oligonucleotide, yielding a total length of 170 bp. A sample oligonucleotide sequence is provided in 
Figure 5.2. 
Figure 5.1. Design of the guide RNA sequences. After the 20 bp guide sequence is chosen, the HR 
regions are designed so after homologous recombination, an 8bp deletion occurs around the PAM 















20 bp guide sequence 
Figure 5.2. Design of a sample oligonucleotide from 5’ to 3’. 
 6,459 ORF sequences from the S. cerevisiae S288c strain were passed through CRISPRdirect (24, 
34) to generate all possible guide sequences. Guide sequences with hit_20mer > 0 were kept to exclude 
those targeting exon-intron junctions. A guide-specific 100 bp HR donor was assembled to the 5’ of each 
guide sequence. All assembled sequences were passed through four additional filters: no BsaI restriction 
site (to facilitate Golden Gate assembly), no homopolymer of more than four T’s (to prevent early 
transcription termination), and no homopolymer of more than five A’s or more than five G’s (to maximize 
oligonucleotide synthesis efficiency). Each guide sequence was then assigned an arbitrary score for 
assessing both genome editing efficiency and off-target effect (Table 5.1). For each ORF, the top four guide 
sequences with the highest scores were selected for synthesis. Adapters containing priming sites and BsaI 
sites were added to the 5’ and 3’ ends of each oligonucleotide for PCR amplification and Golden Gate 
assembly. The designed oligonucleotide library was synthesized on two 12472 format chips and eluted into 











Condition Multiplier (M) 
GC number 1/3 
7 to 15 (including 
7 and 15) 
1 
Less than 7 or 
more than 15 
0 
Composition of the 
last four nucleotides 
1/3  0.25×(#G)+0.2×(#A)+0.15×(#C) 
PAM position 1/3 
Within the first 
60% of the ORF 
1 
Between 60% 
and 80% of the 
ORF 
0.85 
Within the last 





Total score 100×(Wi×Mi)/(hit_12mer)2 
Table 5.1. Criteria for scoring each 20 bp guide sequence. hit_12mer is the number of target sites within 
the genome that share the same 12 bp seed sequence. 
 
 ORF targeting Control Total 
Guide # 1 2 3 4 5 6 100 24765 
ORF # 261 100 92 6003 2 1 NA 6459 
Table 5.2. Guide sequence distribution within the designed oligonucleotide library. 
 
To design a genome-wide screening library, we first obtained the sequence and chromosomal 
coordinates of all the non-essential coding sequences in the genome from the genome knock out database 
(35). A custom application program interface (API) was then developed in Python programming language 
to communicate with the CRISPRdirect CRISPR design webserver to send the coordinates to the website 
and to receive the list of all possible crRNAs. For coding sequences larger than 10 kb, the region was broken 
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into two parts and each part was sent separately and combined together later. The gRNAs obtained from 
the website for each gene was then sorted as explained above (Table 5.1) based on the GC content, distance 
from the start codon, number of off-target sites and the 4 bp next to the PAM sequence which has shown 
to be very important for double stranded break efficiency. The right and left hand homology arms (RHA 
and LHA) were then designed so that an 8 bp deletion is introduced in the genome which causes disruption 
of gene function. All of the designed components (LHA, cRNA, RHA) were then put together and the 
sequences were searched for particular sequences that can affect the DNA synthesis, DNA cloning, and 
gRNA expression as described previously (10). All sequences that contained homopolymers of more than 
6 A’s, four T’s, six G’s and six C’s were removed from the list and were replaced with the next best 
sequences. 
 Introducing point mutations to change all of the amino acid residues in one protein proved to be 
more difficult than disruption of that corresponding gene. On average, there are 85 regions in each gene 
that can be targeted for disruption due to the relative abundance of the PAM sequences in the genome. 
Moreover, any of these sequences can be chosen and targeted based on the efficiency and availability. 
However, because the PAM sequence may not be present in long stretches of a gene, and that the efficiency 
of the mutation decreases as the distance between the PAM sequence and the guide increases, there is much 
less flexibility in designing guides for point mutations. 
 
Figure 5.3. The design of the guide RNA sequence for point mutation. After the target codon is chosen, 
the best PAM sequence is located in its vicinity and the homology arms are designed to make the 
designed library. Figure adapted from (28). 
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In order to design the guide RNA to target and mutate the codon of interest, it is first located and 
the codon with the highest usage in yeast is chosen to replace it and the rest of the guide is designed 
accordingly. After the codon is found and the new sequence is designed, all PAM sequences within 40 bp 
are separated and sorted based on the same criteria as shown in Table 5.1 except that the distance from the 
start codon is replaced by distance from the target codon. The left and right homology arms are also 
designed such that the PAM sequence is silently mutated. In some cases, the PAM sequence cannot be 
silently mutated because either both of the sequences coding for that codon contain NGG (Proline) or the 
PAM is placed between two codons where mutating both of them could not result in PAM disruption. In 
any case, the PAM sequence is changed to the most different synonymous mutation and if the PAM 
sequence cannot be mutated at all, the bases immediately adjacent to the PAM sequence are silently mutated 
so that the guide is not able to target the mutated sequence. Since the maximum number of bases in each 
synthesized oligo is 170, if the chosen PAM is too far from the codon, the homology arms are shortened 
and if they are too close, a few random bases are added to the end to make the size of all oligos 170 bases. 
CRISPR-AID: Activation, Interference and Deletion 
Having developed the design principles and algorithms for deletion and point mutation of all genes 
in S. cerevisiae, we sought to develop a tri-functional system for activation, interference and deletion of all 
genes in the S. cerevisiae genome using three orthogonal CRISPR proteins, one for activation, one for 
interference, and one for deletion (CRISPR-AID). It was shown that using the optimized CRISPR-AID, 5-
fold activation of a red fluorescent protein, 5-fold interference of a yellow fluorescent protein, and >95% 
deletion of an endogenous gene was achieved simultaneously by transforming a single plasmid into yeast 
(29). To perform the activation and interference, an activation domain and a repression domain were fused 
to a nuclease deficient mutant of Cas9 and Cpf1 proteins, respectively, and they could increase or decrease 
the expression level of the genes of interest respectively (Figure 5.4). CRISPRdirect was used in the design 
of the guides for the knock out library as described in the previous section, however, this program has major 
limitations which makes it unsuitable for the CRISPR-AID library design. The biggest limitation is 
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inflexibility of the PAM sequence which is important when other nucleases with different PAM sequences 
are used which are required in the CRISPR-AID method.  The CHOPCHOP guide RNA design tool was 
used instead because of the availability of the source code, the very flexible scoring system and the 
availability of a variety of PAM sequences to choose from.  
 
Figure 5.4. Design of CRISPR-AID for combinatorial metabolic engineering. (a) Cell factories for 
sustainable production of fuels, chemicals, and drugs from renewable resources. (b) Development of 
CRISPR-AID using three orthogonal CRISPR proteins, one nuclease-deficient CRISPR protein fused with 
an activation domain for CRISPRa, another nuclease-deficient mutant fused with a repression domain for 
CRISPRi, and a third catalytically active CRISPR protein for CRISPRd. (c) CISPR-AID enabled 
combinatorial metabolic engineering by exploring all the possible gRNA combinations to construct optimal 
cell factories. Figure adapted from (29)  
All coding sequences were chosen from the yeast genome database and their coordinates were 
extracted (https://www.yeastgenome.org). The entire coding sequences for all the genes were given to the 
CHOPCHOP software for designing deletion guides and the regions around the start codon for designing 
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activation and interference guides. All guide RNAs were designed for the genes and sorted based on some 
criteria taking into account the binding efficiency, off-target effects, binding location, and the DNA 
synthesis efficiency, most of which were different due to the intricacies and differences for guides in each 
application. The general score is as follows: 
S= (1+ Efficiency -A-B-C-D)*E*F*G*H 
Where Efficiency is the efficiency score which is calculated by the program using different algorithms 
explained in a previous section, and the rest of parameters are penalties for certain criteria which is 
explained more in each section. The definition of these parameters are shown in Table 5.3. 
Variable Penalty for 
A Position penalty (X=0 is start codon) 
B GC penalty 
C Off target penalty 
D Poly T penalty 
E Poly G penalty 
F BsaI penalty 
G Cluster penalty 
H Beyond range penalty 
Table 5.3. Variables used in the scoring system.  
Gene deletion 
The Cas9 protein from Staphylococcus aureus (SaCas9) (36, 37) was chosen for gene deletion, the 
G20 scoring system was chosen and the value was given to the Efficiency score. Since the closer the 
disruption point is to the start codon, the more effective the function is disrupted, a higher weight was given 
to the guides that can disrupt the first third of the coding sequence (CDS). The position and other penalties 
were defined and are shown in Table 5.4: 
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Variable Condition Value 
A (Distance from ATG=X 
Length of the CDS=CDS) 
X/CDS<=0.33 0 
 0.33<X/CDS<=0.67 0.2 
 0.67<X/CDS 0.5 
B (GC content=X) All |X-50|/50 
C All (SM+MM0+MM1+MM2+MM3)/20 
D (#Consecutive Ts =X) X<4 0 
 4<X<5 0.5 
 5<X 1 
E  Max(#consecutive A,C,G,T)>5 0 
 Else 1 
F  BsaI exists 0 
 BsaI does not exist 1 
H All 1 
Table 5.4. Scores used for ranking and choosing the best guides for gene deletion 
Gene activation 
As described before, by mutating the nuclease domains in the Cas9 and Cpf1 proteins, the 
deactivated proteins only bind to the target but do not cleave it. This dCpf1 protein can then be fused to an 
activator and when attached to the promoter region, increase the expression of the protein of interest. To 
develop the CRISPR-AID method, the deactivated Cpf1 protein from Lachnospiraceae bacterium ND2006 
with a medium strength activation domain (dLbCpf1-VP) (38, 39) was chosen. The dLbSpf1-VP gRNAs 
were also designed with CHOPCHOP software with an efficiency score suggested by Doench and 
coworkers (21). Based on the experimental data (40–42), the activation is most effective if the target region 
is ~250 bp upstream of the start codon. This difference is also reflected in the scoring of guides for activation 
(Table 5.5).  
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Variable Condition Value 
A (X= location relative to ATG) All |X+250|/250 
B (GC content=X) All |X-50|/50 
Table 5.5 Variables in the scoring system that differs between gene activation and gene deletion  
Gene Interference 
 The deactivated Cas9 protein from Streptococcus pyogenes fused with a repression domain 
(dspCas9-RD1152) was used for interfering with the expression of the target genes. Based on previous 
studies, it was found that the region between 100-150 bp upstream of the coding sequence or 50-100 bp 
upstream of transcription starting site (TSS) worked the best for CRISPRi by blocking transcriptional 
initiation while those targeting the non-template strand of the coding sequences worked the best for 
CRISPRi by blocking transcriptional elongation. This was reflected in the scoring for guides for 
interference. Since some coding sequences might be smaller than 150 bp, another variable (H) is also 
defined so that guides that are targeting outside of the gene of interest are not designed. The parameters 
used in scoring guides for interference are shown in Table 5.6. 
Variable Condition Value 
A (X= location relative to ATG) X<0 |X+125|/125 
 X>=0 and from T strand 0.25 
 X>=0 and from NT strand 1 
H  Position>CDS length 0 
 Else  1 
Table 5.6 Variables in scoring system that differ between gene interference and deletion  
More than 1,300,000 guide RNAs were designed for each of the Activation, Interference and 
Deletion libraries and ranked based on these criteria. 37,719 guides were synthesized for activation, 37,771 
for interference and 24,806 for deletion and transformation and screening was performed to find the effect 
of these mutations on a variety of different phenotypes.  
 91 
 
5.2.2. iBioCAD: a large-scale plasmid assembly tool 
As described in previous chapters, in many cases, high-throughput screening is not available which 
makes the use of genome scale libraries almost impossible. The library screening size for most genome 
scale projects are in the ~107 order of magnitude which is difficult to do using low to medium throughput 
assays such as HPLC. In these cases, large numbers of plasmids must be designed and assembled which is 
very difficult and error-prone to do manually.  
Here, we developed a computer aided design software, iBioCAD (Figure 5.5a), which enables 
researchers to design and assemble a large number of variations of the same plasmid. This software allows 
the user to choose one of the four methods-Golden Gate (43), Ligase Chaining Reaction (LCR) (44), DNA 
assembler  (45) or Gibson assembly (46) and to design the primers for the assemblies. The program can be 
found at http://ibiocad.igb.illinois.edu/ and some of its features are described below: 
Multiple input and export formats and dynamic nodes  
When using the web-app, the user inputs multiple DNA parts based on the construct they want to 
assemble. There are multiple ways to input parts, firstly the user can individual parts from files in FASTA 
format (and can be expanded to include other file formats such as Genbank). A second way is to manually 
input the name, type (promoter, Coding sequence (CDS), terminator, Ribosome Binding Site (RBS), and 
origins of replication), and sequence (with an optional description) of the part as shown in Figure 5.5b. 
There is also a library of parts already in the system that can be selected from. Finally, a “dynamic node” 
can be created with a given name that contains multiple parts that represent the same position in a 
combinatorial pathway (Figure 5.5c). This feature enables the user to create combinations of multiple parts 
and assemble hundreds of plasmid variants in just a few clicks. 
After being input, the parts are stored as objects and displayed in accordance with the Synthetic 
Biology Open Language (SBOL) Visual Model (47–49). The symbols that represent the parts can be 
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dragged-and-dropped to be rearranged or can be deleted. The parts in the construct can also be exported as 
sequence files such as FASTA. Using the SBOL 2.0 Data Model (50), the whole construct can be saved in 
eXtensible Markul Language (XML) format and constructs can be loaded in if the files are in the same 
format.  
 
Figure 5.5. Input features of iBioCAD software. A) iBioCAD logo, B) Static and FASTA import, C) 
Multi-sequence import using the dynamic node function. 
 
DNA assembly methods 
After the parts to be assembled are designed and configured, the finished construct can be 
assembled using one of four assembly methods using the “Assemble” button (Figure 5.6). Both the yeast-
based DNA assembler and the Gibson assembly rely on sequence homology between overlapping DNA 
regions. They are sequence-independent and “scar-less” methods, meaning no unwanted nucleotides are 
inserted between two assembled sequences. The LCR assembly method uses bridging oligos 
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complimentary to the parts and is also sequence-independent and scar-less. However, these bridging oligos 
must be designed to have a melting temperature of around 70oC, so large DNA assemblies would be 
computationally intensive. The Golden Gate assembly method is mediated by restriction enzymes and 
facilitates one-pot assembly of combinatorial libraries. Because this method uses restriction enzymes, the 
assembled parts cannot contain the enzyme recognition site within their sequences; this makes the assembly 
method sequence-dependent. It also leaves a four-base scar between assembled parts.  
 
Figure 5.6. The DNA assembly interface on the iBioFAB. The DNA parts can be imported to the software 
using a variety of methods, the parts can be moved around by simply dragging and dropping them. The 
name and size of the part is shown by hovering over it. DNA assembly methods as well as some settings 
can be chosen on the left control panel. 
 
Scar-less Golden Gate assembly 
Another unique feature of iBioCAD, other than combinatorial plasmid assembly design, is a scar-
less variant of the Golden Gate assembly, as described in Chapter 4. Whereas the regular Golden Gate 
assembly attaches four-base overhangs to the ends of the DNA parts, the scar-less variant searches for 
naturally-occurring four-base overhangs in the regions around the junctions where the two parts are 
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assembled. Using optimization algorithms, the web-app computes a design such that each junction between 
the assembled parts uses a unique four-base overhang. The oligonucleotide between each overhang and its 
corresponding junction is transferred to the other end of the junction (appended to the beginning/end of the 
other part of the junction). Searching and optimizing the four-base overhangs is computationally intensive, 
however, the resulting assembly is scar-less. One constraint on the scar-less variant is that it requires each 
junction to use a unique four-base overhang; there are certain scenarios in which there is no solution that 
can use a unique overhang for each junction. The likelihood of these scenarios can be vastly minimized by 
having multiple options for sets of overhangs or increasing the size of each set of overhangs, a problem 
which was addressed and resolved in the experiments described in Chapter 4. 
When the scar-less Golden Gate assembly is performed, the algorithm takes a given set of 
overhangs that has been experimentally found to be efficient in Chapter 4 and catalogs which of the 
overhangs in this set are found in the region (radius of ~30 bp) around each junction. Once this is done for 
every junction, the algorithm attempts to find a solution in which each junction uses a unique overhang not 
used by any other junction. To make sure that the best sets of overhangs are chosen, the web-app has many 
possible sets of overhangs it can use to search through all the junctions. It has five sets of overhangs for 
each size of 10 through 50. The algorithm begins with an overhang set with a size equal to the number of 
junctions in the assembly (minimum of 10). If the algorithm does not find a solution where each junction 
uses a unique overhang, it moves to the next set of overhangs. If none of the sets of overhangs of a given 
size can find a solution, the algorithm moves to the next size of overhangs. If none of the 200 sets of 
overhangs can find a solution, the web-app returns an error message stating “there may be some 
fundamental problems with the assembly preventing efficient assembly.” 
The scar-less Golden Gate variant can also be used to remove naturally occurring restriction 
enzyme recognition sites within the DNA sequences. In the regular Golden Gate, naturally occurring 
enzyme recognition sites will cause mis-assembly. A given 6-base sequence has an extremely high chance 
of appearing at least once in each DNA sequence, so this severely limits the practical scope of the regular 
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Golden Gate variant. The scar-less variant, however, is not constrained by this problem. For each sequence 
that contains a recognition site, iBioCAD treats the site as a junction and finds a nearby four-base overhang. 
The assembly is performed at the overhang and the naturally occurring site is subjected to silent mutation, 
functionally inactivating the recognition site. As this method creates another junction for each DNA part 
that contains a naturally occurring recognition site, the algorithm gets more computationally intensive with 
each naturally occurring site.  
As user control is prioritized, there is a configuration page in the web-app that offers variability in 
the design; some examples of options are changing the backbone vector sequence, altering the homology 
arm length for yeast and Gibson assembly, altering the melting temperature for the LCR assembly, and 
selecting which variant of the Golden Gate assembly to perform. These configurations are highly 
expandable to add popularly demanded features.  
Once the assembly is performed, an output page is displayed on the web-app that displays each 
DNA part as well as the backbone along with their types, sequences, descriptions, and their corresponding 
forward and reverse primer sequences (Figure 5.7). This page has an option to be exported in .CSV format, 
facilitating large-scale assemblies and transfer of the assembly data between systems (so that the assembly 




Figure 5.7. The results page shows the promoters needed for assembling each construct. The promoters 
can be exported in Comma Separated Variable (CSV) format and, ready for DNA synthesis.  
 
5.3. Conclusion and prospects 
Here, we developed two pieces of software to facilitate large-scale design of both plasmids and guide 
RNAs for combinatorial pathway engineering as well as genome-wide genome editing and engineering. 
The pathway assembly method has been used to design variants of different pathways. It includes unique 
features like seamless Golden Gate assembly and high-throughput combinatorial pathway design. A few 
features can be added to this software in future iterations from more flexible and optimized assembly 
algorithms to suggestions on which algorithm to use. It can also be integrated to the iBioFAB platform to 
enable seamless integration of pathway design with pathway construction. 
Another piece of software was developed by using CRISPRdirect and CHOPCHOP as the basis 
which enables high-throughput design and sorting of gRNAs for targeting all the genes in yeast genome 
and to perform activation, interference, deletion or point mutations. More than 1,000,000 guide RNAs were 
designed using this program and ~120,000 of them were synthesized and used in a variety of projects like 
improving furfural tolerance in yeast. 
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Chapter 6: High-throughput Gel Electrophoresis 
6.1. Introduction 
Gel electrophoresis is one of the most important techniques in molecular biology and has been 
extensively used for the past 40 years. It is a very effective way of separating DNA molecules with different 
sizes and has been used for a variety of applications in molecular biology (1). Size differentiation using gel 
electrophoresis can be used to verify DNA constructs after cloning by restriction digestion (2, 3). It can also 
be used to evaluate the purity of DNA molecules before sequencing or simply purification of DNA before 
cloning after PCR reaction. The PCR product in many cases is run on a gel and the desired band is cut and 
purified to avoid DNA contamination of non-specific bands (4). 
Slab gels are the most common form of DNA electrophoresis in which a molding polymer like 
agarose is used in combination with a conductive medium like Tris Acetate EDTA (TAE) buffer. A comb 
is used in the casting process to create wells in the gel to make running multiple DNA samples on the gel 
possible. After the samples are loaded to the gel, an electric potential will be induced to the sides of the gel 
and DNA will start migrating to the positive end of the gel. DNA molecules with different sizes move at 
different speeds and therefore, get separated on the gel slab. Gel slabs can be used both for qualitative 
assessment of DNA sizes and separation of DNA molecules of different sizes. Although this method has 
been extremely popular and useful in the past, it scales very poorly. Usually up to 7 samples can be run on 
a gel at the same time for verification and even fewer (2 samples) for purification which significantly limits 
the throughput of experiments if running the gel is a key step in the workflow. This low throughput 
combined with the footprint of gel slab electrophoresis which is about 1 sq ft for running each gel 
significantly hinders its suitability for being used for large scale purification. 
Another type of electrophoresis is capillary electrophoresis, in this case very small capillary tubes 
are used, and the DNA is passed through them using a much larger electric field. This method has a lot 
higher throughput and (up to 96 samples can be run simultaneously and the run time is a little longer, ~2 
 104 
hours). However, capillary electrophoresis can only run the gels for confirmation or verification. There is 
no way for the DNA to be purified after being run on this instrument because the volume of samples loaded 
to capillary devices is very small and there is no way to collect the desired bands from the capillary tubes 
(5). 
Here we developed a vertical high-throughput gel electrophoresis system that can be used for the 
separation of DNA molecules with different sizes as well as the purification of the desired DNA sizes in a 
high-throughput manner. After full implementation, this will resolve one of the most important challenges 
in high-throughput cloning which is DNA purification. 
6.2. Materials and methods 
6.2.1. Gel preparation and casting 
 All gel slabs created in this work were made by dissolving 1g UltraPure Agarose in 100 mL of 
TAE buffer (ThermoFisher Scientific). The TAE buffer and agarose were mixed and heated to completely 
dissolve the agarose, and then the mixture is cast in different shapes and forms. Similarly, Sodium Borate 
gels were cast by substituting TAE buffer with 5mM disodium borate decahydrate solution. 200ul of the 
dissolved and molten agarose solution was aspirated in a pipette tip and left in room temperature for 10 
minutes to solidify. 
6.2.2. DNA visualization 
 10 μL of 100X SYBR Green DNA stain was mixed with 10 μL of the DNA samples and incubated 
in room temperature for 10 min before being added to the gel. The static visualization was done using Gel 
Doc XR Gel documentation system (BIORAD, Hercules, CA), and the gel live images were taken using an 
ApoTome microscope (Zeiss) using 490/520 excitation/emission filters. 
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6.3. Results 
6.3.1. Testing the vertical gel electrophoresis 
 To perform gel electrophoresis in a more high-throughput manner, we set to perform DNA 
separation in vertical tubes which can be placed in parallel to reduce the footprint of gel electrophoresis as 
shown in Figure 6.1a. The DNA migrates through the gel in the tubes due to the electric field and when 
the desired band reaches the collection tube, the electric field will be stopped, and the purified DNA can be 
easily collected. To test the effectiveness of DNA migration and separation in a vertical setting, 1 kb DNA 
ladder was added to a gel cast in a tube and was run for 20 minutes. This was tested in a plastic tube and 
the DNA fragments in the DNA ladder were successfully separated as shown in Figure 6.1b. 
       
    a      b 
Figure 6.1. Vertical gel electrophoresis setup. (a) DNA sample is loaded to the left side of the figure. After 
the electric field is started, it will migrate to the other side and as soon as the desired band is detected on 
the bottom, the electric field stops and the DNA is recovered. (b) The left side of this system was tested as 
a proof of concept to make sure vertical gel electrophoresis works. The bands in 1 kb ladder have been 
separated as they would in a gel slab. 
 
 We then set to try the U-shaped gel electrophoresis as shown in Figure 6.1a to see if the DNA 
migrates from one side of the device to the other. However, it was observed that when the DNA was 
migrating in the tube, the gel on the positive electrode kept shrinking and after 30 minutes, it started leaking 
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and the electrophoresis would stop. We realized that the TAE buffer is not suitable for electrophoresis in 
small volumes of gel and buffer. 
6.3.2. Buffer optimization 
The reason for gel shrinking is believed to be Electro Osmosis (EEO) where the positive ions that 
are bound to the water molecules move through the matrix. The positive ions transport water molecules 
with them as they move through the gel matrix resulting in a net transport of water out of the gel. This 
causes the positive side of the U shaped gel to get dehydrated and shrink while the buffer on the negative 
side over-flows (6).  
To solve this problem, Sodium Borate and Lithium Acetate solutions were tested and Sodium 
Borate was found to be the most effective. This solution has less conductivity and hence fewer positive 
ions. This not only improves the efficiency of gel electrophoresis by reducing the EEO, the lower 
conductivity results in lower current which in turn reduces the electrolysis and buffer depletion. The new 
design was then tested in the same U-shaped format as before and the EEO was significantly reduced and 
no significant shrinkage of the gel was observed (7). 
To obtains higher resolution and easier gel casting, pipette tips were used instead of the previously 
used tubes. Using this conical shaped vessel, the DNA bands would get concentrated at one point and enter 





Figure 6.2. The DNA migration in pipette tips resulted in more efficient gel casting using the existing and 
optimized tips and pipettes. It will be very easy to cast in large scale as well since the gel can be cast 
using a liquid handler robot. It also increases the resolution of DNA separation by concentrating the DNA 
band to one small point. 
 
6.3.3. Quantification of separation resolution 
We then sought to quantify the resolution of gel electrophoresis and used a light filter with a cutoff 
wavelength of 515 nm to separate the excitation and emission lights and visualize the DNA migration in 
real time. A time lapse video was generated showing migration and we observed that the bands moved from 
the separation column to the collection column. We then visualized the DNA migration in the collection 
channel by using an Apotome microscope in the Institute for Genomic Biology core facilities. We took time 
lapse videos of the movement of DNA in the collection tube and observed that bands with more than 300 
bp difference can be separated from each other if the size is less than 1 kb and bands with more than 500 
bp difference can be separated if the size is less than 3 kb. Separation of the bands larger than 3 kb was not 
as efficient since the Sodium Borate media makes it more difficult for larger bands to separate. 
6.3.4. Prototyping the gel electrophoresis device 
The instrument manifold as well as the tip holder was designed using SolidWorks.  The 3D model 
as well as the printed version is shown in Figure 6.3. The disposable gel separation and DNA purification 
system on the left is put on the visualization manifold. The electrodes will then be picked up from the holder 
by the robotic arm and put on top of the gel separation system. The electric field then starts and stops as the 
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desired band reaches the collection tube in the bottom. After all the electrodes are stopped, the electrode 
plate will be removed and placed back on the holder. The separation plate will be then removed and 
discarded and the remaining liquid in the collection plate will be removed by the liquid handler for 
downstream purification and processing. The entire process of DNA separation and purification takes 





Figure 6.3. The CAD model of the vertical gel electrophoresis device and the 3D printed setup. In this 
design, 48 DNA samples can be run at the same time in a fully-automated manner. 
 
6.4. Future work 
Here, we successfully demonstrated size dependent DNA separation using vertical gel 
electrophoresis. We can potentially separate 48 DNA samples with different expected sizes in a footprint 
of ~1 sq. ft. However, there are some challenges that still need to be addressed for successful and robust 
separation of the DNA samples. 
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The circuit design must be worked out where the current and ΔV in each well can be individually 
controlled. The safety features are especially important because the ΔV will be ~300V and designing the 
electrophoresis device which contains liquid with 96 electrodes can be rather challenging and reasonable 
precautions must be taken to avoid short circuiting. 
Image processing is another area that needs significant improvement. For this device to work, one 
lane must be loaded with DNA ladder and an image processing algorithm should keep track of the bands 
that pass through the collection tube and stop the current for the wells that the correct band has reached the 
collection tube. 
Another problem that was observed was the depletion of the buffer in the electrodes, especially the 
positive electrode. Water electrolysis reduces the ions in the buffer by reacting with them and making the 
buffer less conductive. In these experiments, this problem was solved by replenishing the buffer every 5 
minutes, but this is not a sustainable solution in the large scale run on a fully automated system. One of the 
proposed solutions which have been shown to work in electrophoresis in microfluidic systems is using an 
electrode that can be consumed as part of the electrophoresis instead of water being electrolyzed. This 
method can greatly reduce the buffer depletion and potentially eliminate the need for replenishing the buffer 
(8). 
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